Original Article
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
N Engl J Med 2007; 356:1503-1516April 12, 2007
- Abstract
Background
In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events.
Methods
We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6).
Results
There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33).
Conclusions
As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657.)
Media in This Article
Figure 1
Enrollment and Outcomes.Figure 2
Kaplan–Meier Survival Curves.Article Activity
- Article
During the past 30 years, the use of percutaneous coronary intervention (PCI) has become common in the initial management strategy for patients with stable coronary artery disease in North America, even though treatment guidelines advocate an initial approach with intensive medical therapy, a reduction of risk factors, and lifestyle intervention (known as optimal medical therapy).1,2 In 2004, more than 1 million coronary stent procedures were performed in the United States,3 and recent registry data indicate that approximately 85% of all PCI procedures are undertaken electively in patients with stable coronary artery disease.4 PCI reduces the incidence of death and myocardial infarction in patients who present with acute coronary syndromes,5-10 but similar benefit has not been shown in patients with stable coronary artery disease.11-15 This issue has been studied in fewer than 3000 patients,16 many of whom were treated before the widespread use of intracoronary stents and current standards of medical management.17-28
Although successful PCI of flow-limiting stenoses might be expected to reduce the rate of death, myocardial infarction, and hospitalization for acute coronary syndromes, previous studies have shown only that PCI decreases the frequency of angina and improves short-term exercise performance.11,12,15 Thus, the long-term prognostic effect of PCI on cardiovascular events in patients with stable coronary artery disease remains uncertain. Our study, the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial, was designed to determine whether PCI coupled with optimal medical therapy reduces the risk of death and nonfatal myocardial infarction in patients with stable coronary artery disease, as compared with optimal medical therapy alone.
Methods
Study Design
The methods we used in the trial have been described previously.29,30 Sponsorship and oversight of the trial were provided by the Department of Veterans Affairs Cooperative Studies Program. Additional funding was provided by the Canadian Institutes of Health Research. Supplemental corporate support from several pharmaceutical companies included funding and in-kind support. All support from the pharmaceutical industry consisted of unrestricted research grants payable to the Department of Veterans Affairs.
The study protocol was approved by the human rights committee at the coordinating center and by the local institutional review board at each participating center. An independent data and safety monitoring board oversaw the conduct, safety, and efficacy of the trial. Data management and statistical analyses were performed solely by the data coordinating center with oversight by the trial executive committee, whose members, after unblinding, had full access to the data and vouch for the accuracy and completeness of the data and the analyses. The companies that provided financial support, products, or both had no role in the design, analysis, or interpretation of the study.
Study Population
Patients with stable coronary artery disease and those in whom initial Canadian Cardiovascular Society (CCS) class IV angina subsequently stabilized medically were included in the study. Entry criteria included stenosis of at least 70% in at least one proximal epicardial coronary artery and objective evidence of myocardial ischemia (substantial changes in ST-segment depression or T-wave inversion on the resting electrocardiogram or inducible ischemia with either exercise or pharmacologic vasodilator stress) or at least one coronary stenosis of at least 80% and classic angina without provocative testing. Exclusion criteria included persistent CCS class IV angina, a markedly positive stress test (substantial ST-segment depression or hypotensive response during stage 1 of the Bruce protocol), refractory heart failure or cardiogenic shock, an ejection fraction of less than 30%, revascularization within the previous 6 months, and coronary anatomy not suitable for PCI. A detailed description of the inclusion and exclusion criteria is included in the Supplementary Appendix (available with the full text of this article at www.nejm.org). Patients who were eligible for the study underwent randomization after providing written informed consent.
Treatment
Patients were randomly assigned to undergo PCI and optimal medical therapy (PCI group) or optimal medical therapy alone (medical-therapy group). A permuted-block design was used to generate random assignments within each study site along with previous coronary-artery bypass grafting (CABG) as a stratifying variable. All patients received antiplatelet therapy with aspirin at a dose of 81 to 325 mg per day or 75 mg of clopidogrel per day, if aspirin intolerance was present. Patients undergoing PCI received aspirin and clopidogrel, in accordance with accepted treatment guidelines and established practice standards. Medical anti-ischemic therapy in both groups included long-acting metoprolol, amlodipine, and isosorbide mononitrate, alone or in combination, along with either lisinopril or losartan as standard secondary prevention. All patients received aggressive therapy to lower low-density lipoprotein (LDL) cholesterol levels (simvastatin alone or in combination with ezetimibe) with a target level of 60 to 85 mg per deciliter (1.55 to 2.20 mmol per liter). After the LDL cholesterol target was achieved, an attempt was made to raise the level of high-density lipoprotein (HDL) cholesterol to a level above 40 mg per deciliter (1.03 mmol per liter) and lower triglyceride to a level below 150 mg per deciliter (1.69 mmol per liter) with exercise, extended-release niacin, or fibrates, alone or in combination.
In patients undergoing PCI, target-lesion revascularization was always attempted, and complete revascularization was performed as clinically appropriate. Success after PCI as seen on angiography was defined as normal coronary-artery flow and less than 50% stenosis in the luminal diameter after balloon angioplasty and less than 20% after coronary stent implantation, as assessed by visual estimation of the angiograms before and after the procedure. Clinical success was defined as angiographic success plus the absence of in-hospital myocardial infarction, emergency CABG, or death. Drug-eluting stents were not approved for clinical use until the final 6 months of the study, so few patients received these intracoronary devices.
Clinical Outcome
Clinical outcome was adjudicated by an independent committee whose members were unaware of treatment assignments. The primary outcome measure was a composite of death from any cause and nonfatal myocardial infarction. Secondary outcomes included a composite of death, myocardial infarction, and stroke and hospitalization for unstable angina with negative biomarkers. The angina status of patients was assessed according to the CCS classification during each visit. Further analyses of other secondary outcomes — including quality of life, the use of resources, and cost-effectiveness — are being conducted but have not yet been completed.
The prespecified definition of myocardial infarction (whether periprocedural or spontaneous) required a clinical presentation consistent with an acute coronary syndrome and either new abnormal Q waves in two or more electrocardiographic leads or positive results in cardiac biomarkers. Silent myocardial infarction, as detected by abnormal Q waves, was confirmed by a core laboratory and was also included as an outcome of myocardial infarction.
Statistical Analysis
We projected composite 3-year event rates of 21.0% in the medical-therapy group and 16.4% in the PCI group (relative difference, 22%) during a follow-up period of 2.5 to 7.0 years. We also incorporated assumptions about crossover between study groups and loss to follow-up.31 We estimated that the enrollment of 2270 patients would provide a power of 85% to detect the anticipated difference in the primary outcome at the 5% two-sided level of significance. A detailed description of the sample-size calculation is included in the Supplementary Appendix.
Estimates of the cumulative event rate were calculated by the Kaplan–Meier method,32 and the primary efficacy of PCI, as compared with optimal medical therapy, was assessed by the stratified log-rank statistic.33 The treatment effect, as measured by the hazard ratio and its associated 95% confidence interval (CI), was estimated with the use of the Cox proportional-hazards model.34 Data for patients who were lost to follow-up were censored at the time of the last contact. Analyses were performed according to the intention-to-treat principle. Categorical variables were compared by use of the chi-square test or the Wilcoxon rank-sum test, and continuous variables were compared by use of the Student t-test. Adjusted analysis of the primary outcome was performed with the use of a Cox proportional-hazards regression model with eight preidentified covariates of interest — age, sex, race, previous myocardial infarction, extent or distribution of angiographic coronary artery disease, ejection fraction, presence or absence of diabetes, and health care system (Veterans Affairs or non–Veterans Affairs facility in the United States, or a Canadian facility) — as well as the stratifying variable of previous CABG. All other comparisons were unadjusted. A level of significance of less than 0.01 was used for all subgroup analyses and interactions.
Results
Baseline Characteristics and Angiographic Data
Between June 1999 and January 2004, a total of 2287 patients were enrolled in the trial at 50 U.S. and Canadian centers (Figure 1Figure 1
Enrollment and Outcomes.). Of these patients, 1149 were randomly assigned to the PCI group and 1138 to the medical-therapy group. The baseline characteristics of the patients were recently published35 and were similar in the two groups (Table 1Table 1
Baseline Clinical and Angiographic Characteristics.). The median time from the first episode of angina before randomization was 5 months (median, three episodes per week, with exertion or at rest), and 58% of patients had CCS class II or III angina. A total of 2168 patients (95%) had objective evidence of myocardial ischemia, whereas the remaining 119 patients with classic angina (CCS class III) and severe coronary stenoses did not undergo ischemia testing (56 in the PCI group and 63 in the medical-therapy group). Among patients who underwent myocardial perfusion imaging at baseline, 90% had either single (23%) or multiple (67%) reversible defects for inducible ischemia. Two thirds of the patients had multivessel coronary artery disease.Of the 1149 patients in the PCI group, 46 never underwent a procedure because the patient either declined treatment or had coronary anatomy unsuitable for PCI, as determined on clinical reassessment. In 27 patients (2%), the operator was unable to cross any lesions. PCI was attempted for 1688 lesions in 1077 patients, of whom 1006 (94%) received at least one stent. In the stent group, 590 patients (59%) received one stent and 416 (41%) more than one stent. Drug-eluting stents were used in 31 patients. On average, stenosis in the luminal diameter, as evaluated on visual assessment of angiograms, was reduced from a mean (±SD) of 83±14% to 31±34% in the 244 lesions not treated with stents and from 82±12% to 1.9±8% in the 1444 lesions treated with stents. After PCI, successful treatment as seen on angiography was achieved in 1576 of 1688 lesions (93%), and clinical success (i.e., all lesions successfully dilated and no in-hospital complications) was achieved in 958 of 1077 patients (89%).
Medication and Treatment Targets
Patients had a high rate of receiving multiple, evidence-based therapies after randomization and during follow-up, with similar rates in both study groups (Table 2Table 2
Clinical Status, Risk and Lifestyle Factors, and Use of Medication.). At the 5-year follow-up visit, 70% of subjects had an LDL cholesterol level of less than 85 mg per deciliter (2.20 mmol per liter) (median, 71±1.3 mg per deciliter [1.84±0.03 mmol per liter]); 65% and 94% had systolic and diastolic blood pressure targets of less than 130 mm Hg and 85 mm Hg, respectively; and 45% of patients with diabetes had a glycated hemoglobin level of no more than 7.0% (Table 2). Patients had high rates of adherence to the regimen of diet, regular exercise, and smoking cessation as recommended by clinical practice guidelines,1,2 although the mean body-mass index did not decrease.Follow-up Period
The median follow-up period was 4.6 years (interquartile range, 3.3 to 5.7) and was similar in the two study groups, with a total of 120,895 patient-months at risk. Only 9% of patients were lost to follow-up in the two groups (107 in the PCI group and 97 in the medical-therapy group, P=0.51) before the occurrence of a primary outcome or the end of follow-up. Vital status was not ascertained in 194 patients (99 in the PCI group and 95 in the medical-therapy group, P=0.81).
Primary Outcome
The primary outcome (a composite of death from any cause and nonfatal myocardial infarction) occurred in 211 patients in the PCI group and 202 patients in the medical-therapy group (Table 3Table 3
Primary and Secondary Outcomes.). The estimated 4.6-year cumulative primary event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (unadjusted hazard ratio for the PCI group, 1.05; 95% CI, 0.87 to 1.27; P=0.62) (Figure 2Figure 2Kaplan–Meier Survival Curves.).Secondary Outcomes
For the prespecified composite outcome of death, nonfatal myocardial infarction, and stroke, the event rate was 20.0% in the PCI group and 19.5% in the medical-therapy group (hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62) (Table 3 and Figure 2). The rates of hospitalization for acute coronary syndromes were 12.4% in the PCI group and 11.8% in the medical-therapy group (hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56), and adjudicated rates of myocardial infarction were 13.2% and 12.3%, respectively (hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). For death alone, the rates were 7.6% and 8.3%, respectively (hazard ratio, 0.87; 95% CI, 0.65 to 1.16); the mortality curves for the two groups were virtually identical during the initial 4.6 years of the study. For stroke alone, the rate was 2.1% in the PCI group and 1.8% in the medical-therapy group (hazard ratio, 1.56; 95% CI, 0.80 to 3.04; P=0.19). When the primary end point was calculated with the exclusion of periprocedural myocardial infarction, the event rates were 16.2% and 17.9% (hazard ratio, 0.90; 95% CI, 0.73 to 1.10; P=0.29).
At a median follow-up of 4.6 years, 21.1% of patients in the PCI group had additional revascularization, as compared with 32.6% of those in the medical-therapy group (hazard ratio, 0.60; 95% CI, 0.51 to 0.71; P<0.001). In the PCI group, 77 patients subsequently underwent CABG, as compared with 81 patients in the medical-therapy group. Revascularization was performed for angina that was unresponsive to maximal medical therapy or when there was objective evidence of worsening ischemia on noninvasive testing, at the discretion of the patient's physician. The median time to subsequent revascularization was 10.0 months (interquartile range, 4.5 to 28.0) in the PCI group and 10.8 months (interquartile range, 3.2 to 30.7) in the medical-therapy group.
There was a substantial reduction in the prevalence of angina in both groups during follow-up. There was a statistically significant difference in the rates of freedom from angina throughout most of the follow-up period, in favor of the PCI group (Table 2). At 5 years, 74% of patients in the PCI group and 72% of those in the medical-therapy group were free of angina (P=0.35).
Subgroup Analyses
There was no significant interaction (P<0.01) between treatment effect and any predefined subgroup variable (Figure 3Figure 3
Subgroup Analyses.). Of note, among patients with multivessel coronary artery disease, previous myocardial infarction, and diabetes, the rate of the primary end point was similar for both groups. When subgroup variables were included in a multivariate analysis, the hazard ratio for treatment was essentially unchanged (1.09; 95% CI, 0.90 to 1.33; P=0.77).Discussion
As an initial management strategy, PCI added to optimal medical therapy did not reduce the primary composite end point of death and nonfatal myocardial infarction or reduce major cardiovascular events, as compared with optimal medical therapy alone, during follow-up of 2.5 to 7.0 years, despite a high baseline prevalence of clinical coexisting illnesses, objective evidence of ischemia, and extensive coronary artery disease as seen on angiography. Although the degree of angina relief was significantly higher in the PCI group than in the medical-therapy group, there was also substantial improvement in the medical-therapy group. All secondary outcomes and individual components of the primary outcome showed no significant differences between the study groups, nor was there a significant interaction between treatment effect and any prespecified subgroup variable. For the primary outcome, the 95% CI excludes a relative benefit of more than 13% in the PCI group. Thus, it is highly unlikely that we missed a prognostically important treatment benefit in favor of the initial PCI strategy.
Our findings may be explained, in part, by differences in atherosclerotic plaque morphology and vascular remodeling associated with acute coronary syndromes, as compared with stable coronary artery disease. Vulnerable plaques (precursors of acute coronary syndromes) tend to have thin fibrous caps, large lipid cores, fewer smooth-muscle cells, more macrophages, and less collagen, as compared with stable plaques, and are associated with outward (expansive) remodeling of the coronary-artery wall, causing less stenosis of the coronary lumen.36 As a result, vulnerable plaques do not usually cause significant stenosis before rupture and the precipitation of an acute coronary syndrome.36 By contrast, stable plaques tend to have thick fibrous caps, small lipid cores, more smooth-muscle cells, fewer macrophages, and more collagen and are ultimately associated with inward (constrictive) remodeling that narrows the coronary lumen. These lesions produce ischemia and anginal symptoms and are easily detected by coronary angiography but are less likely to result in an acute coronary syndrome.37,38
Thus, unstable coronary lesions that lead to myocardial infarction are not necessarily severely stenotic, and severely stenotic lesions are not necessarily unstable. Focal management of even severely stenotic coronary lesions with PCI in our study did not reduce the rate of death and myocardial infarction, presumably because the treated stenoses were not likely to trigger an acute coronary event. Furthermore, our lower-than-projected event rate in the medical-therapy group may be explained by systemic therapy that reduced plaque vulnerability through aggressive intervention for multiple risk factors and evidence-based use of medication.
Rates of angina were consistently lower in the PCI group than in the medical-therapy group during follow-up, and rates of subsequent revascularization were likewise lower. However, there was a substantial increase in freedom from angina in patients in the medical-therapy group as well, most of which had taken place at 1 year but with a further improvement at 5 years. To what extent this finding reflects a benefit of specific antianginal medications (e.g., nitrates and beta-blockers) or a favorable effect of therapies such as statins on endothelial function and atherosclerosis is unclear.
Our findings parallel those reported in recent trials,39,40 in which observed clinical-event rates that were associated with optimal medical therapy were lower than projected in the trial design. These results are also concordant with a meta-analysis of all previous trials involving PCI versus medical management.16 In the aggregate, these studies, including our own, include outcome data on more than 5000 patients and show that PCI has no effect in reducing major cardiovascular events.
The preponderance of male patients (85%) is a limitation of our study, as is the lack of ethnic diversity (14% of the patients were nonwhite). We used bare-metal stents, since drug-eluting stents were not available until late during accrual. Although the latter factor may be perceived as a limitation, published data indicate no benefit (either short-term or long-term) with respect to death and myocardial infarction in patients with stable coronary artery disease who receive drug-eluting stents, as compared with those who receive bare-metal stents.41-46
Our findings reinforce existing clinical practice guidelines, which state that PCI can be safely deferred in patients with stable coronary artery disease, even in those with extensive, multivessel involvement and inducible ischemia, provided that intensive, multifaceted medical therapy is instituted and maintained.1,2 As an initial management approach, optimal medical therapy without routine PCI can be implemented safely in the majority of patients with stable coronary artery disease. However, approximately one third of these patients may subsequently require revascularization for symptom control or for subsequent development of an acute coronary syndrome.
In summary, our trial compared optimal medical therapy alone or in combination with PCI as an initial management strategy in patients with stable coronary artery disease. Although the addition of PCI to optimal medical therapy reduced the prevalence of angina, it did not reduce long-term rates of death, nonfatal myocardial infarction, and hospitalization for acute coronary syndromes.
Supported by the Cooperative Studies Program of the U.S. Department of Veterans Affairs Office of Research and Development, in collaboration with the Canadian Institutes of Health Research; and by unrestricted research grants from Merck, Pfizer, Bristol-Myers Squibb, Fujisawa, Kos Pharmaceuticals, Datascope, AstraZeneca, Key Pharmaceutical, Sanofi-Aventis, First Horizon, and GE Healthcare. All industrial funding in support of the trial was directed through the U.S. Department of Veterans Affairs.
Dr. Boden reports receiving consulting fees and lecture fees from Kos Pharmaceuticals, PDL BioPharma, Pfizer, CV Therapeutics, and Sanofi-Aventis, and grant support from Merck and Abbott Laboratories; Dr. O'Rourke, consulting fees from King Pharmaceuticals, Lilly, and CV Therapeutics; Dr. Teo, grant support from Boehringer Ingelheim; Dr. Knudtson, lecture fees from Medtronic and Lilly; Dr. Harris, having equity ownership in Amgen; Dr. Chaitman, receiving consulting fees from CV Therapeutics, Merck, and Bayer, lecture fees from Pfizer, AstraZeneca, and CV Therapeutics, and grant support from Pfizer, CV Therapeutics, and Sanofi-Aventis; Dr. Shaw, grant support from Bristol-Myers Squibb and Astellas Healthcare; Dr. Booth, grant support from Actelion; Dr. Bates, consulting fees from Sanofi-Aventis and AstraZeneca and lecture fees from Sanofi-Aventis; Dr. Spertus, consulting fees from Amgen and United Healthcare and grant support from Amgen, Roche Diagnostics, and Lilly (and in the past, consulting fees and grant support from CV Therapeutics and owning the copyright for the Seattle Angina Questionnaire, the Peripheral Artery Questionnaire, and the Kansas City Cardiomyopathy Questionnaire); Dr. Berman, consulting fees and lecture fees from Bristol-Myers Squibb, Astellas, Tyco, and Siemens and grant support from Bristol-Myers Squibb and Astellas; Dr. Mancini, consulting and lecture fees from Pfizer, Abbott, and GlaxoSmithKline, lecture fees from Merck and Sanofi-Aventis, and grant support from Cordis and GlaxoSmithKline; and Dr. Weintraub, consulting fees from Sanofi-Aventis and Bristol-Myers Squibb and grant support from Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.
This article (10.1056/NEJMoa070829) was published at www.nejm.org on March 26, 2007.
Source Information
Affiliations for all authors are listed in the Appendix.
Address reprint requests to Dr. Boden at the Division of Cardiology, Buffalo General Hospital, 100 High St., Buffalo, NY 14203, or at wboden@kaleidahealth.org.
Members of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial are listed in the Appendix and in the Supplementary Appendix, available with the full text of this article at www.nejm.org.
Appendix
The authors' affiliations are as follows: Western New York Veterans Affairs (VA) Healthcare Network and Buffalo General Hospital–SUNY, Buffalo, NY (W.E.B.); South Texas Veterans Health Care System–Audie Murphy Campus, San Antonio, TX (R.A.O., P.C.); McMaster University Medical Center, Hamilton, ON, Canada (K.K.T.); VA Cooperative Studies Program Coordinating Center, VA Connecticut Healthcare System, West Haven, CT (P.M.H); Vanderbilt University Medical Center, Nashville (D.J.M); London Health Sciences Centre, London, ON, Canada (W.J.K.); Foothills Hospital, Calgary, AB, Canada (M.K.); Hartford Hospital, Hartford, CT (M.D.); VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM (C.L.H.); Saint Louis University, St. Louis (B.R.C.); Cedars–Sinai Medical Center, Los Angeles (L.S., D.S.B.); Montreal Heart Institute, Montreal (G. Gosselin); Sudbury Regional Hospital, Sudbury, ON, Canada (S.N.); Queen Elizabeth Health Sciences Centre, Halifax, NS, Canada (L.M.T.); Mayo Clinic, Rochester, MN (G. Gau); Houston VA Medical Center, Houston (A.S.B.); Lexington VA Medical Center, Lexington, KY (D.C.B.); University of Michigan Medical Center, Ann Arbor (E.R.B.); Mid America Heart Institute, Kansas City, MO (J.A.S.); Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada (G.B.J.M.); and Christiana Care Health System, Newark, DE (W.S.W.).
The members of the COURAGE trial were as follows: Writing Committee: W. Boden (study cochair), R. O'Rourke (study cochair) K. Teo (study cochair), P. Hartigan. W. Weintraub, D. Maron, J. Mancini; Executive Committee: W. Weintraub (chair), W. Boden, R. O'Rourke, K. Teo, P. Hartigan, M. Knudtson, D. Maron, E. Bates, A. Blaustein, D. Booth, R. Carere, S. Ellis, G. Gosselin, G. Gau, A. Jacobs, S. King, III, W. Kostuk, C. Harris, J. Spertus; P. Peduzzi (ex officio); Data and Safety Monitoring Board: T. Ryan (chair), B. Turnbull, T. Feldman, R. Bonow, W. Haskell, P. Diehr, P. Lachenbruch, D. Waters, D. Johnstone; Adjudication Committee: L. Cohen (chair), B. Cantin, W. Hager, F. Samaha, J. Januzzi, J. Arrighi, B. Chaitman; Economics Committee: W. Weintraub (chair), P. Hartigan, R. O'Rourke, W. Boden, P. Barnett, J. Spertus, R. Goeree; Optimal Medical Therapy Committee: D. Maron (chair), W. Boden, R. O'Rourke, K. Teo, W. Weintraub.
The following members assisted in coordination of the study: VA Cooperative Studies Program Coordinating Center, VA Connecticut Healthcare System, West Haven, CT — P. Peduzzi (director); M. Antonelli, (associate director of operations); J. Smith (project manager); R. Kilstrom, B. Hunter (coordinators); L. Durant (quality assurance officer); S. O'Neil (end points coordinator); T. Economou, J. Nabors (programmers); A. Kossack (data clerk); VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM — M. Sather (director), C. Harris (assistant director), W. Gagne (project manager), C. Fye (pharmacist); VA Cooperative Studies Human Rights Committee, West Haven, CT — R. Marottoli (chair), H. Allore, D. Beckwith, W. Farrell, R. Feldman, R. Mehta, J. Neiderman, E. Perry, S. Kasl, M. Zeman; VA Office of Research and Development, Clinical Science Research and Development, Washington, DC — T. O'Leary (acting director), G. Huang (deputy director, Cooperative Studies Program); Study Chairs Offices — Western New York VA Healthcare Network and Buffalo General Hospital–SUNY, Buffalo, NY — W. Boden (study cochair), M. Dada, K. Potter (national coordinators), T. Rivera (program assistant); South Texas Veterans Health Care System, San Antonio, TX — R. O'Rourke (study cochair), P. Casperson (national coordinator), A. O'Shea (program assistant); McMaster University Medical Center, Hamilton, ON, Canada — K. Teo (study cochair), G. Woodcock (coordinator); Laboratories: Christiana Care Center for Outcomes Research, Newark, DE, and Emory University, Atlanta — W. Weintraub; Health Economics Research Center, Menlo Park, CA — P. Barnett; Program for Assessment of Technology in Health, Hamilton, ON, Canada — R. Goeree, B. O'Brien; Vancouver Hospital, Cardiovascular Imaging Research Core Laboratory, Vancouver, BC, Canada — G.B.J. Mancini, E. Yeoh; Washington University Central Lipid Core Laboratory, St. Louis — J. Ladenson, V. Thompson; Saint Louis University ECG Core Laboratory, St. Louis — B. Chaitman, T. Bertran; Cedars–Sinai Medical Center Nuclear Core Laboratory, Los Angeles — D. Berman, J. Gerlach, R. Littman, L. Shaw; San Diego State University PACE Program, San Diego, CA — K. Calfas, J. Sallis.
The following investigators are listed according to their clinical study sites: VA: South Texas Veterans Health Care System, San Antonio, TX — R. O'Rourke, P. Baker, J. Bolton; VA Medical Center, Houston — A. Blaustein, C. Rowe; VA Medical Center, Durham, NC — K. Morris, S. Hoffman; VA Health Care System, New York — S. Sedlis, M. Keary; VA Health Care System, Ann Arbor, MI — C. Duvernoy, C. Majors; VA Medical Center, Lexington, KY — Booth, M. Shockey; James A. Haley Veterans Hospital, Tampa, FL — R. Zoble, I. Fernandez; VA Health Care System, Puget Sound, WA — K. Lehmann, A. Sorley, M. Abel; VA Health Care System, Albuquerque, NM — M. Sheldon, K. Wagoner; Portland VA Medical Center, Portland, OR — E. Murphy, K. Avalos; Iowa City VA Medical Center, Iowa City — J. Rossen, K. Schneider; Central Arkansas Veterans Health Care System, Little Rock, AR — B. Molavi, L. Garza, P. Barton; VA Medical Center, Atlanta — K. Mavromatis, Z. Forghani; Tennessee Valley Health Care System, Nashville — R. Smith, C. Mitchell; VA Medical Center, Memphis, TN — K. Ramanathan, T. Touchstone. Canada: London Health Sciences Centre, London, ON — W. Kostuk, K. Sridhar, S. Carr, D. Wiseman; Sudbury Regional Hospital, Sudbury, ON — S. Nawaz, C. Dion; Montreal Heart Institute, Montreal — G. Gosselin, J. Theberge, M. Cuso; Queen Elizabeth II Health Care Center, Halifax, NS — L. Title, P. Simon, L. Carroll, K. Courtney-Cox; Sunnybrook Health Care Centre, Toronto — E. Cohen, E. Hsu; University Health Network–Toronto Hospital, Toronto — V. Dzavik, J. Lan; Foothills Hospital, Calgary, AB — M. Knudtson, D. Lundberg; Hamilton General Hospital–McMaster Clinic, Hamilton, ON — M. Natarajan, G. Cappelli; St. Michael's Hospital, Toronto — M. Kutryk, A. DiMarco, B. Strauss; Vancouver Hospital, Vancouver, BC — A. Fung, J. Chow; Saint John Regional Hospital, Saint John, NB — D. Marr, F. Fitzgerald; St. Paul's Hospital, Vancouver, BC — R. Carere, T. Nacario; University of Alberta Hospital, Edmonton — W. Tymchak, L. Harris; Trillium Health Care, Newmarket, ON — C. Lazzam, A. Carter; Hôpital du Sacre Coeur de Montreal, Montreal — D. Palisaitis, C. Mercure. U.S. Non-VA: Mayo Clinic, Rochester, MN — M. Bell, M. Peterson; MIMA Century Research Associates, Melbourne, FL — R. Vicari, M. Carroll; University of Michigan Medical Center, Ann Arbor — E. Bates, A. Luciano; Southern California Kaiser Permanente Medical Group, CA — P. Mahrer; S. Reyes; University of Oklahoma, Oklahoma City — J. Saucedo, D. vanWieren; Mid America Heart Institute, St. Louis — J. O'Keefe, P. Kennedy; Boston Medical Center, Boston — A. Jacobs. C. Berger, S. Mayo; Emory University Hospital, Atlanta — J. Miller, T. Arnold; Hartford Hospital, Hartford, CT — F. Kiernan, D. Murphy; Henry Ford Health System, Detroit — A. Kugelmass, R. Pangilinan; University of Rochester Medical Center, Rochester, NY — R. Schwartz, L. Caufield; Vanderbilt University Hospital, Nashville — D. Hansen, C. Mitchell; SUNY University Hospital, Syracuse, NY — R. Carhart, A. Pennella; Cleveland Clinic, Cleveland — S. Ellis, C. Stevenson; Barnes–Jewish Hospital, St. Louis — R. Krone, J. Humphrey; Mayo Clinic, Scottsdale, AZ — C. Appleton, J. Wisbey; Christiana Care Health Systems, Wilmington, DE — M. Stillabower, A. DiSabatino; Rush–Presbyterian–St. Luke's Medical Center, Chicago — M. Davidson, J. Mathien.
- References
References
1
Gibbons RJ ,Abrams J ,Chatterjee K , et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina -- summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-168
CrossRef | Medline2
Smith SC Jr ,Feldman TE ,Hirshfeld JW Jr , et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention -- summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:156-175
CrossRef | Medline3
Rosamond W ,Flegal K ,Friday G , et al. Heart disease and stroke statistics -- 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-e171
CrossRef | Web of Science | Medline4
Feldman DN ,Gade CL ,Slotwiner AJ , et al. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry). Am J Cardiol 2006;98:1334-1339
CrossRef | Web of Science | Medline5
Antman EM ,Anbe DT ,Armstrong PW , et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction -- executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:588-636[Erratum, Circulation 2005;111:2013.]
CrossRef | Medline6
Keeley EC ,Boura JA ,Grines CL . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20
CrossRef | Web of Science | Medline7
Fragmin and Fast Revascularisation during InStability in Coronary artery disease Investigators
CrossRef | Web of Science | Medline8
Cannon CP ,Weintraub WS ,Demopoulos LA , et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887
Full Text | Web of Science | Medline9
Fox KA ,Poole-Wilson PA ,Henderson RA , et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial: Randomized Intervention Trial of unstable Angina. Lancet 2002;360:743-751
CrossRef | Web of Science | Medline10
Mehta SR ,Cannon CP ,Fox KA , et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908-2917
CrossRef | Web of Science | Medline11
Parisi AF ,Folland ED ,Hartigan P . A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-16
Full Text | Web of Science | Medline12
Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-468
CrossRef | Web of Science | Medline13
Pitt B ,Waters D ,Brown WV , et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999;341:70-76
Full Text | Web of Science | Medline14
Hueb W ,Soares PR ,Gersh BJ , et al. The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004;43:1743-1751
CrossRef | Web of Science | Medline15
Henderson RA ,Pocock SJ ,Clayton TC , et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003;42:1161-1170
CrossRef | Web of Science | Medline16
Katritsis DG ,Ioannidis JP . Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005;111:2906-2912
CrossRef | Web of Science | Medline17
Yusuf S ,Wittes J ,Friedman L . Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988;260:2088-2093
CrossRef | Web of Science | Medline18
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-1714
CrossRef | Web of Science19
Pfeffer MA ,Braunwald E ,Moye LA , et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992;327:669-677
Full Text | Web of Science | Medline20
The SOLVD Investigators
Full Text | Web of Science | Medline21
The Heart Outcomes Prevention Evaluation Study Investigators
Full Text | Web of Science | Medline22
Fox KM . Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-788
CrossRef | Web of Science | Medline23
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389
Web of Science | Medline24
Heart Protection Study Collaborative Group
CrossRef | Web of Science | Medline25
LaRosa JC ,Grundy SM ,Waters DD , et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-1435
Full Text | Web of Science | Medline26
The Clopidogrel in Unstable Angina to Prevent Events Trial Investigators
Full Text | Web of Science | Medline27
de Lorgeril M ,Salen P ,Martin JL ,Monjaud I ,Delaye J ,Mamelle N . Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-785
Web of Science | Medline28
O'Connor GT ,Buring JE ,Yusuf S , et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80:234-244
CrossRef | Web of Science | Medline29
Boden WE ,O'Rourke RA ,Teo KK , et al. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424. Am Heart J 2006;151:1173-1179
CrossRef | Web of Science | Medline30
Weintraub WS ,Barnett P ,Chen S , et al. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. Am Heart J 2006;151:1180-1185
CrossRef | Web of Science | Medline31
Shih JH . Sample size calculation for complex clinical trials with survival endpoints. Control Clin Trials 1995;16:395-407
CrossRef | Medline32
Kaplan EL ,Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
CrossRef | Web of Science33
Schoenfeld DA ,Tsiatis AA . A modified log rank test for highly stratified data. Biometrika 1987;74:167-175
CrossRef | Web of Science34
Cox DR . Regression models and life-tables. J R Stat Soc [B] 1972;34:187-22035
Boden WE ,O'Rourke RA ,Teo KK , et al. The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardiol 2007;99:208-212
CrossRef | Web of Science | Medline36
Naghavi M ,Libby P ,Falk E , et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Circulation 2003;108:1664-1672
CrossRef | Web of Science | Medline37
Ambrose JA ,Tannenbaum MA ,Alexopoulos D , et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62
CrossRef | Web of Science | Medline38
Little WC ,Constantinescu M ,Applegate RJ , et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-1166
CrossRef | Web of Science | Medline39
Hochman JS ,Lamas GA ,Buller CE , et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006;355:2395-2407
Full Text | Web of Science | Medline40
de Winter RJ ,Windhausen F ,Cornel JH , et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005;353:1095-1104
Full Text | Web of Science | Medline41
Curfman GD ,Morrissey S ,Jarcho JA ,Drazen JM . Drug-eluting coronary stents: promise and uncertainty. N Engl J Med 2007;356:1059-1060
Full Text | Web of Science | Medline42
Spaulding C ,Daemen J ,Boersma E ,Cutlip DE ,Serruys PW . A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-997
Full Text | Web of Science | Medline43
Stone GW ,Moses JW ,Ellis SG , et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008
Full Text | Web of Science | Medline44
Kastrati A ,Mehilli J ,Pache J , et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-1039
Full Text | Web of Science | Medline45
Lagerqvist B ,James SK ,Stenestrand U ,Lindback J ,Nilsson T ,Wallentin L . Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019
Full Text | Web of Science | Medline46
Mauri L ,Hsieh W ,Massaro JM ,Ho KKL ,D'Agostino R ,Cutlip DE . Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029
Full Text | Web of Science | Medline
- Citing Articles (649)
Citing Articles
1
2012. References. , 348-358.
CrossRef2
Deborah H. Kwon, Rory Hachamovitch. (2012) Cost-Effectiveness of Cardiac Magnetic Resonance. Current Cardiovascular Imaging Reports
CrossRef3
Vinay Prasad, Adam Cifu. (2012) A medical burden of proof: Towards a new ethic. BioSocieties
CrossRef4
D. G. Katritsis, M. E. Josephson. (2012) Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?. Europace
CrossRef5
Eugene T. Richardson, Alina Polyakova. (2012) The illusion of scientific objectivity and the death of the investigator. European Journal of Clinical Investigation 42:2, 213-215
CrossRef6
Martin H. Reed. (2012) Evidence in Diagnostic Imaging: Going Beyond Accuracy. Journal of the American College of Radiology 9:2, 90-92
CrossRef7
Steven P. Marso, Paul S. Teirstein, Dean J. Kereiakes, Jeffrey Moses, John Lasala, J. Aaron Grantham. (2012) Percutaneous Coronary Intervention Use in the United States. JACC: Cardiovascular Interventions
CrossRef8
Robert J. Mentz, Mona Fiuzat, Linda K. Shaw, Harry R. Phillips, Salvador Borges-Neto, G. Michael Felker, Christopher M. O'Connor. (2012) Comparison of Clinical Characteristics and Long-Term Outcomes of Patients With Ischemic Cardiomyopathy With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease). The American Journal of Cardiology
CrossRef9
Joanne Shannon, Antonio Colombo. (2012) Revascularization in multivessel CAD: a functional approach. Nature Reviews Cardiology
CrossRef10
An S De Vriese, Stefaan J Vandecasteele, Barbara Van den Bergh, Frank W De Geeter. (2012) Should we screen for coronary artery disease in asymptomatic chronic dialysis patients?. Kidney International 81:2, 143-151
CrossRef11
Marco D. Huesch. (2012) Long-term Impact of Medicare Managed Care on Patients Treated for Coronary Artery Disease. Medical Care 50:1, 18-26
CrossRef12
Soo-Jin Kang, Jung-Min Ahn, Haegeun Song, Won-Jang Kim, Jong-Young Lee, Duk-Woo Park, Sung-Cheol Yun, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park. (2012) Usefulness of Minimal Luminal Coronary Area Determined by Intravascular Ultrasound to Predict Functional Significance in Stable and Unstable Angina Pectoris. The American Journal of Cardiology
CrossRef13
Gary R Small, Benjamin JW Chow, Terrence D Ruddy. (2012) Low-dose cardiac imaging: reducing exposure but not accuracy. Expert Review of Cardiovascular Therapy 10:1, 89-104
CrossRef14
L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter, Michael E. Jessen, Ellen C. Keeley, Stephen J. Lahey, Richard A. Lange, Martin J. London, Michael J. Mack, Manesh R. Patel, John D. Puskas, Joseph F. Sabik, Ola Selnes, David M. Shahian, Jeffrey C. Trost, Michael D. Winniford, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Frederick G. Kushner, E. Magnus Ohman, William Stevenson, Clyde W. Yancy. (2012) 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary. The Journal of Thoracic and Cardiovascular Surgery 143:1, 4-34
CrossRef15
B. S. Ko, J. D. Cameron, I. T. Meredith, M. Leung, P. R. Antonis, A. Nasis, M. Crossett, S. A. Hope, S. J. Lehman, J. Troupis, T. DeFrance, S. K. Seneviratne. (2012) Computed tomography stress myocardial perfusion imaging in patients considered for revascularization: a comparison with fractional flow reserve. European Heart Journal 33:1, 67-77
CrossRef16
Felix Mahfoud, Michael Böhm, Magnus Baumhäkel. (2012) Inadequate Reporting of Concomitant Drug Treatment in Cardiovascular Interventional Head-to-Head Trials. Clinical Cardiologyn/a-n/a
CrossRef17
C. Richard Conti, Anthony A. Bavry, John W. Petersen. (2012) Silent Ischemia. Journal of the American College of Cardiology 59:5, 435-441
CrossRef18
Tatsiana Suvorava, Vu Thao-Vi Dao, Murat Bas, Georg Kojda. (2012) Nitric oxide and the CABG patient. Current Opinion in Pharmacology
CrossRef19
Marcus R. Makowski, Sarah C. Forbes, Ulrike Blume, Alice Warley, Christian H.P. Jansen, Andreas Schuster, Andrea J. Wiethoff, René M. Botnar. (2012) In vivo assessment of intraplaque and endothelial fibrin in ApoE−/− mice by molecular MRI. Atherosclerosis
CrossRef20
C. Korsukéwitz, J. Falk, B. Lindow. (2011) Kardiologische Rehabilitation in Deutschland. Herz
CrossRef21
Michael Fiechter, Jelena R. Ghadri, Mathias Wolfrum, Silke M. Kuest, Aju P. Pazhenkottil, Rene N. Nkoulou, Bernhard A. Herzog, Cathérine Gebhard, Tobias A. Fuchs, Oliver Gaemperli, Philipp A. Kaufmann. (2011) Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device. European Journal of Nuclear Medicine and Molecular Imaging
CrossRef22
Alberto Cordero, Vicente Bertomeu-González, Pilar Mazón, José Moreno-Arribas, Lorenzo Fácila, Héctor Bueno, Jose R. González-Juanatey, Vicente Bertomeu-Martínez. (2011) Differential Effect of β-Blockers for Heart Rate Control in Coronary Artery Disease. Clinical Cardiology 34:12, 748-754
CrossRef23
I. S. Toor, R. Jaumdally, G. Y. H. Lip, D. Pagano, W. Dimitri, T. Millane, C. Varma. (2011) Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention. International Journal of Clinical Practice 65:12, 1259-1266
CrossRef24
Wouter G Wieringa, Gabija Pundziute, Tineke P Willems, Bart JGL de Smet. (2011) Clinical advances in imaging: how useful is computed tomography for guiding and evaluating cardiac interventions. Interventional Cardiology 3:6, 663-678
CrossRef25
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Journal of the American College of Cardiology 58:24, e44-e122
CrossRef26
J.-L. Pasquié, J. Thireau, J.-M. Davy, J.-Y. Le Guennec, S. Richard. (2011) Médicaments anti-arythmiques : Présent et futur. Archives of Cardiovascular Diseases Supplements 3:3, 236-243
CrossRef27
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary. Journal of the American College of Cardiology 58:24, 2550-2583
CrossRef28
Michael J. Zellweger, Matthias E. Pfisterer. (2011) Therapeutic Strategies in Patients with Chronic Stable Coronary Artery Disease. Cardiovascular Therapeutics 29:6, e23-e30
CrossRef29
Jamieson M. Bourque, George A. Beller. (2011) Stress Myocardial Perfusion Imaging for Assessing Prognosis: An Update. JACC: Cardiovascular Imaging 4:12, 1305-1319
CrossRef30
M Kozuch, P Kralisz, J Korecki, M Rog-Makal, P Prokopczuk, H Bachorzewska-Gajewska, K Nowak, B Poniatowski, E Sitniewska, B Sobkowicz, W J Musial, M Jozwowicz, R Sabiniewicz, S Dobrzycki. (2011) Early and long-term prognosis of patients with coronary artery disease treated with percutaneous coronary interventions in 2005. Experience of single large-volume PCI center. Advances in Medical Sciences 56:2, 222-230
CrossRef31
George Hahalis, George Dangas, Periklis Davlouros, Dimitrios Alexopoulos. (2011) Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: From BARI to SYNTAX. International Journal of Cardiology 153:2, 126-134
CrossRef32
L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter, Michael E. Jessen, Ellen C. Keeley, Stephen J. Lahey, Richard A. Lange, Martin J. London, Michael J. Mack, Manesh R. Patel, John D. Puskas, Joseph F. Sabik, Ola Selnes, David M. Shahian, Jeffrey C. Trost, Michael D. Winniford. (2011) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Journal of the American College of Cardiology 58:24, e123-e210
CrossRef33
Juan-Carlos Kaski, Antonio Arrebola-Moreno, Jason Dungu. (2011) Treatment strategies for chronic stable angina. Expert Opinion on Pharmacotherapy 12:18, 2833-2844
CrossRef34
Kyung Woo Park, Ki-Hyun Jeon, Si-Hyuk Kang, Il-Young Oh, Hyun-Jai Cho, Hae-Young Lee, Hyun-Jae Kang, Sue K. Park, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim. (2011) Clinical Outcomes of High On-Treatment Platelet Reactivity in Koreans Receiving Elective Percutaneous Coronary Intervention (from Results of the CROSS VERIFY Study). The American Journal of Cardiology 108:11, 1556-1563
CrossRef35
Megan Coylewright, Kenneth Rice, Matthew J. Budoff, Roger S. Blumenthal, Philip Greenland, Richard Kronmal, R. Graham Barr, Gregory L. Burke, Russell Tracy, Wendy S. Post. (2011) Differentiation of severe coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 219:2, 616-622
CrossRef36
Chang-Wook Nam, William F Fearon. (2011) Role of the functional SYNTAX score in evaluating multivessel coronary artery disease. Interventional Cardiology 3:6, 695-704
CrossRef37
A. Blanchet Deverly, M. Amara, L. Larifla, F.L. Velayoudom-Céphise, F. Roques, P. Kangambega, K. Hue, L. Foucan. (2011) Silent myocardial ischaemia and risk factors in a diabetic Afro-Caribbean population. Diabetes & Metabolism 37:6, 533-539
CrossRef38
David J. Maron, Gregg W. Stone, Daniel S. Berman, G. B. John Mancini, Theresa A. Scott, Daniel W. Byrne, Frank E. Harrell, Leslee J. Shaw, Rory Hachamovitch, William E. Boden, William S. Weintraub, John A. Spertus. (2011) Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists. American Heart Journal 162:6, 1034-1043.e13
CrossRef39
L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter, Michael E. Jessen, Ellen C. Keeley, Stephen J. Lahey, Richard A. Lange, Martin J. London, Michael J. Mack, Manesh R. Patel, John D. Puskas, Joseph F. Sabik, Ola Selnes, David M. Shahian, Jeffrey C. Trost, Michael D. Winniford. (2011) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary. Journal of the American College of Cardiology 58:24, 2584-2614
CrossRef40
Robert O Bonow. (2011) What's past is prologue: advances in cardiovascular imaging. The Lancet
CrossRef41
O. Gaemperli, A. Saraste, J. Knuuti. (2011) Cardiac hybrid imaging. European Journal of Echocardiography
CrossRef42
Sanjeev U. Nair, Alan W. Ahlberg, Shishir Mathur, Deborah M. Katten, Donna M. Polk, Gary V. Heller. (2011) The clinical value of single photon emission computed tomography myocardial perfusion imaging in cardiac risk stratification of very elderly patients (≥80 years) with suspected coronary artery disease. Journal of Nuclear Cardiology
CrossRef43
, , M. Tendera, V. Aboyans, M.-L. Bartelink, I. Baumgartner, D. Clement, J.-P. Collet, A. Cremonesi, M. De Carlo, R. Erbel, F. G. R. Fowkes, M. Heras, S. Kownator, E. Minar, J. Ostergren, D. Poldermans, V. Riambau, M. Roffi, J. Rother, H. Sievert, M. van Sambeek, T. Zeller, , J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, , P. Kolh, A. Torbicki, S. Agewall, A. Blinc, M. Bulvas, F. Cosentino, T. De Backer, A. Gottsater, D. Gulba, T. J. Guzik, B. Jonsson, G. Kesmarky, A. Kitsiou, W. Kuczmik, M. L. Larsen, J. Madaric, J.-L. Mas, J. J. V. McMurray, A. Micari, M. Mosseri, C. Muller, R. Naylor, B. Norrving, O. Oto, T. Pasierski, P.-F. Plouin, F. Ribichini, J.-B. Ricco, L. Ruilope, J.-P. Schmid, U. Schwehr, B. G. M. Sol, M. Sprynger, C. Tiefenbacher, C. Tsioufis, H. Van Damme. (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). European Heart Journal 32:22, 2851-2906
CrossRef44
A. P. Pazhenkottil, R. N. Nkoulou, J.-R. Ghadri, B. A. Herzog, S. M. Kuest, L. Husmann, M. Wolfrum, R. Goetti, R. R. Buechel, O. Gaemperli, T. F. Luscher, P. A. Kaufmann. (2011) Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease. European Heart Journal 32:22, 2824-2829
CrossRef45
Leslee J. Shaw, James K. Min, Rory Hachamovitch, Robert C. Hendel, Salvador Borges-Neto, Daniel S. Berman. (2011) Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT. Journal of Nuclear Cardiology
CrossRef46
Robert A. Henderson, Adam D. Timmis. (2011) Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Revista Portuguesa de Cardiologia 30:11, 869-878
CrossRef47
Vincent E. Friedewald, William E. Boden, Gregg W. Stone, Clyde W. Yancy, William C. Roberts. (2011) The Editor's Roundtable: Role of Percutaneous Coronary Intervention and Drug-Eluting Stents in Patients With Stable Coronary Heart Disease. The American Journal of Cardiology 108:10, 1417-1425
CrossRef48
Joshua M. Stolker, David J. Cohen, Jason B. Lindsey, Kevin F. Kennedy, Neal S. Kleiman, Steven P. Marso. (2011) Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry. American Heart Journal 162:5, 914-921
CrossRef49
Ryusuke Tsunoda, Tomohiro Sakamoto, Sunao Kojima, Yasuhiro Ogata, Akira Kitagwa, Hisao Ogawa. (2011) Recurrence of angina pectoris after percutaneous coronary intervention is reduced by statins in Japanese patients. Journal of Cardiology 58:3, 208-215
CrossRef50
Margaret Holmes-Rovner, Karen Kelly-Blake, Francesca Dwamena, Katherine Dontje, Rebecca C. Henry, Adesuwa Olomu, David R. Rovner, Marilyn L. Rothert. (2011) Shared Decision Making Guidance Reminders in Practice (SDM-GRIP). Patient Education and Counseling 85:2, 219-224
CrossRef51
John S. Gill. (2011) Achieving Fairness in Access to Kidney Transplant: A Work in Progress. American Journal of Kidney Diseases 58:5, 697-699
CrossRef52
Pascal Vranckx, Eric Boersma, Scot Garg, Marco Valgimigli, Gerrit-Anne Van Es, Dick Goedhart, Patrick Serruys. (2011) Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe. EuroIntervention 7:7, 859-871
CrossRef53
W. Schuyler Jones, Manesh R. Patel, Sara A. Holleran, J. Kevin Harrison, Christopher M. O'Connor, Harry R. Phillips. (2011) Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina. American Heart Journal 162:5, 932-937
CrossRef54
Jérôme Thireau, Jean-Luc Pasquié, Eric Martel, Jean-Yves Le Guennec, Sylvain Richard. (2011) New drugs vs. old concepts: A fresh look at antiarrhythmics. Pharmacology & Therapeutics 132:2, 125-145
CrossRef55
Giuseppe Biondi-Zoccai, Imad Sheiban, Enrico Romagnoli, Stefano Servi, Corrado Tamburino, Antonio Colombo, Francesco Burzotta, Patrizia Presbitero, Leonardo Bolognese, Leonardo Paloscia, Paolo Rubino, Gennaro Sardella, Carlo Briguori, Luigi Niccoli, Gianfranco Franco, Domenico Di Girolamo, Luigi Piatti, Cesare Greco, Davide Capodanno, Giuseppe Sangiorgi. (2011) Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry. Clinical Research in Cardiology 100:11, 1021-1028
CrossRef56
Robert A. Henderson, Adam D. Timmis. (2011) Almanac 2011: Stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Revista Portuguesa de Cardiologia (English Edition) 30:11, 869-878
CrossRef57
Jason C. Kovacic, Paul Lee, Usman Baber, Rucha Karajgikar, Solene M. Evrard, Pedro Moreno, Roxana Mehran, Valentin Fuster, George Dangas, Samin K. Sharma, Annapoorna S. Kini. (2011) Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. Atherosclerosis
CrossRef58
Seung-Jung Park, Young-Hak Kim. (2011) Does it pay to be indecisive when considering revascularization during percutaneous coronary intervention?. Interventional Cardiology 3:5, 523-525
CrossRef59
J C Kovacic, V Fuster. (2011) From Treating Complex Coronary Artery Disease to Promoting Cardiovascular Health: Therapeutic Transitions and Challenges, 2010–2020. Clinical Pharmacology & Therapeutics 90:4, 509-518
CrossRef60
F Schwarz, M Treitl, J Grimm, C Cyran, K Nikolaou, M Reiser, T Saam. (2011) The relationship between plaque imaging characterization and treatment modality selection. Interventional Cardiology 3:5, 597-619
CrossRef61
J. Layland, A.M. MacIsaac, A.T. Burns, R.J. Whitbourn, A.M. Wilson. (2011) Integrated Coronary Physiology in Percutaneous Intervention: A new paradigm in interventional cardiology. Heart, Lung and Circulation 20:10, 641-646
CrossRef62
James B. McClurken, Raphael Rosenhek, T. Sloane Guy, Daniel E. Forman. (2011) Risk Stratification in Elderly Coronary Artery Disease Patients: Can We Predict Which Seniors Benefit Most from Revascularization Options?. Current Cardiovascular Risk Reports 5:5, 422-431
CrossRef63
A.A. Rivellese, P.M. Piatti. (2011) Consensus on: Screening and therapy of coronary heart disease in diabetic patients. Nutrition, Metabolism and Cardiovascular Diseases 21:10, 757-764
CrossRef64
Pradeep K. Nair, Oscar C. Marroquin, Suresh R. Mulukutla, Sameer Khandhar, Vijay Gulati, John T. Schindler, Joon S. Lee. (2011) Clinical Utility of Regadenoson for Assessing Fractional Flow Reserve. JACC: Cardiovascular Interventions 4:10, 1085-1092
CrossRef65
Jean-Louis Gayet, Franck Paganelli, Alain Cohen-Solal. (2011) Update on the medical treatment of stable angina. Archives of Cardiovascular Diseases 104:10, 536-544
CrossRef66
F Mangiacapra, B De Bruyne, W Wijns, J Bartunek. (2011) Optimizing Revascularization Strategies in Coronary Artery Disease for Optimal Benefit to Patients. Clinical Pharmacology & Therapeutics 90:4, 630-633
CrossRef67
Inder M. Singh, David R. Holmes. (2011) Myocardial Revascularization by Percutaneous Coronary Intervention: Past, Present, and the Future. Current Problems in Cardiology 36:10, 375-401
CrossRef68
David Moher, Sally Hopewell, Kenneth F. Schulz, Victor Montori, Peter C. Gøtzsche, P.J. Devereaux, Diana Elbourne, Matthias Egger, Douglas G. Altman. (2011) CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. International Journal of Surgery
CrossRef69
Todd D. Miller. (2011) Stress testing. Current Opinion in Cardiology 26:5, 363-369
CrossRef70
O. Gaemperli, F. M. Bengel, P. A. Kaufmann. (2011) Cardiac hybrid imaging. European Heart Journal 32:17, 2100-2108
CrossRef71
J. Matthias Kerl, U. Joseph Schoepf, Peter L. Zwerner, Ralf W. Bauer, Joseph A. Abro, Christian Thilo, Thomas J. Vogl, Christopher Herzog. (2011) Accuracy of coronary artery stenosis detection with CT versus conventional coronary angiography compared with composite findings from both tests as an enhanced reference standard. European Radiology 21:9, 1895-1903
CrossRef72
Anna Tomaszuk-Kazberuk, Marcin Kozuch, Hanna Bachorzewska-Gajewska, Jolanta Malyszko, Slawomir Dobrzycki, Wlodzimierz J. Musial. (2011) Does Lack of ST-Segment Resolution Still Have Prognostic Value 6 Years After an Acute Myocardial Infarction Treated With Coronary Intervention?. Canadian Journal of Cardiology 27:5, 573-580
CrossRef73
Kevin L. Greason, Hartzell V. Schaff. (2011) Myocardial Revascularization by Coronary Arterial Bypass Graft: Past, Present, and Future. Current Problems in Cardiology 36:9, 325-368
CrossRef74
Neal S. Kleiman. (2011) Bringing It All Together. Journal of the American College of Cardiology 58:12, 1219-1221
CrossRef75
Andrew Doorey, Barry Denenberg, Vidya Sagar, Tracy Hanna, Jack Newman, Peter H. Stone. (2011) Comparison of Myocardial Ischemia During Intense Mental Stress Using Flight Simulation in Airline Pilots With Coronary Artery Disease to That Produced With Conventional Mental and Treadmill Exercise Stress Testing. The American Journal of Cardiology 108:5, 651-657
CrossRef76
Chandrasekar Palaniswamy, Wilbert S Aronow. (2011) Treatment of Stable Angina Pectoris. American Journal of Therapeutics 18:5, e138-e152
CrossRef77
Yuhua Liu, Chongren Tang. (2011) Regulation of ABCA1 functions by signaling pathways. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
CrossRef78
Michael P. Thomas, Mauro Moscucci, Dean E. Smith, Herb Aronow, David Share, Phillip Kraft, Hitinder S. Gurm, . (2011) Outcome of Contemporary Percutaneous Coronary Intervention in the Elderly and the Very Elderly: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Clinical Cardiology 34:9, 549-554
CrossRef79
Richard Heuser. (2011) Innovation in interventional cardiology: a thing of the past?. Cardiovascular Revascularization Medicine 12:5, 271-272
CrossRef80
J. Aalten, S. A. Peeters, M. J. van der Vlugt, A. J. Hoitsma. (2011) Is standardized cardiac assessment of asymptomatic high-risk renal transplant candidates beneficial?. Nephrology Dialysis Transplantation 26:9, 3006-3012
CrossRef81
Bernard R. Chaitman, Abhay A. Laddu. (2011) Stable angina pectoris: antianginal therapies and future directions. Nature Reviews Cardiology 9:1, 40-52
CrossRef82
Gerdi Weidner. (2011) Sustainability in medicine: a case for the prevention of chronic non-communicable diseases. The Environmentalist
CrossRef83
Pieter J. Vlaar, Karim D. Mahmoud, David R. Holmes, Gert van Valkenhoef, Hans L. Hillege, Iwan C.C. van der Horst, Felix Zijlstra, Bart J.G.L. de Smet. (2011) Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology 58:7, 692-703
CrossRef84
Vishal C. Mehra, Marietta Ambrose, Carolina Valdiviezo-Schlomp, Karl H. Schuleri, Albert C. Lardo, Joao A. C. Lima, Richard T. George. (2011) CT-Based Myocardial Perfusion Imaging-Practical Considerations: Acquisition, Image Analysis, Interpretation, and Challenges. Journal of Cardiovascular Translational Research 4:4, 437-448
CrossRef85
Sheng-Chia Chung, Mark A. Hlatky, David Faxon, Kodangudi Ramanathan, Dale Adler, Arshag Mooradian, Charanjit Rihal, Roslyn A. Stone, Joyce T. Bromberger, Sheryl F. Kelsey, Maria Mori Brooks. (2011) The Effect of Age on Clinical Outcomes and Health Status. Journal of the American College of Cardiology 58:8, 810-819
CrossRef86
Prakash C. Deedwania, Enrique V. Carbajal. (2011) Medical Therapy Versus Myocardial Revascularization in Chronic Coronary Syndrome and Stable Angina. The American Journal of Medicine 124:8, 681-688
CrossRef87
James C. Blankenship. (2011) Take that, stent nihilists: Additional evidence for the benefits of coronary stenting. Catheterization and Cardiovascular Interventions 78:2, 177-178
CrossRef88
, Oliver Lindner, Wolfgang Burchert, Frank M. Bengel, Rainer Zimmermann, Jürgen Dahl, Michael Schäfers. (2011) Myocardial perfusion scintigraphy in Germany in 2009: utilization and state of the practice. European Journal of Nuclear Medicine and Molecular Imaging 38:8, 1485-1492
CrossRef89
Charles F. Jackson, Nanette K. Wenger. (2011) Enfermedad cardiovascular en el anciano. Revista Española de Cardiología 64:8, 697-712
CrossRef90
Fabio Mangiacapra, Emanuele Barbato. (2011) From SYNTAX to FAME, a paradigm shift in revascularization strategies. Journal of Cardiovascular Medicine 12:8, 538-542
CrossRef91
M. Lindstaedt, A. Mügge. (2011) Myocardial fractional flow reserve. Herz 36:5, 410-416
CrossRef92
Charles F. Jackson, Nanette K. Wenger. (2011) Cardiovascular Disease in the Elderly. Revista Española de Cardiología (English Edition) 64:8, 697-712
CrossRef93
Leslee J. Shaw, Rory Hachamovitch, James Min, Daniel S. Berman. (2011) Importance of Residual Myocardial Ischemia After Intervention in the Genesis of Cardiovascular Events Among Patients with Chronic Coronary Artery Disease. Current Cardiology Reports 13:4, 280-286
CrossRef94
Tust Techasith, Ricardo C. Cury. (2011) Stress Myocardial CT Perfusion. JACC: Cardiovascular Imaging 4:8, 905-916
CrossRef95
Morton J. Kern. (2011) FFR-Guided Percutaneous Intervention in Multivessel Coronary Artery Disease: A Real Game Changer. Current Cardiovascular Imaging Reports 4:4, 263-265
CrossRef96
Purificación Peñasco Iglesias, Rafael Bravo Toledo, Noelia Caballero Encinar. (2011) Un caso inusual de meralgia parestésica. FMC - Formación Médica Continuada en Atención Primaria 18:7, 445-446
CrossRef97
Aviv Tuttnauer, Yuval Meroz, Giora Landesberg. (2011) Risk to and resilience of the coronary heart disease patient during surgery. Current Opinion in Critical Care 17:4, 358-361
CrossRef98
Ali Hassan, Sarfraz Ahmed Nazir, Hatem Alkadhi. (2011) Technical challenges of coronary CT angiography: Today and tomorrow. European Journal of Radiology 79:2, 161-171
CrossRef99
Philip Joseph, Koon Teo. (2011) Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease. Current Cardiology Reports 13:4, 287-295
CrossRef100
James A. Goldstein, Sean P. Madden, Stephen T. Sum, Simon R. Dixon, Ryan D. Madder, James E. Muller. (2011) Assessment of Plaque Composition with Near-Infrared Spectroscopy. Current Cardiovascular Imaging Reports 4:4, 298-308
CrossRef101
A. C. Weustink, P. J. Feyter. (2011) The role of multi-slice computed tomography in stable angina management: a current perspective. Netherlands Heart Journal 19:7-8, 336-343
CrossRef102
Serafina Valente, Chiara Lazzeri, Marco Chiostri, Andrea Sori, Cristina Giglioli, Gian Franco Gensini. (2011) Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role?. Internal and Emergency Medicine 6:4, 329-336
CrossRef103
Young Bin Song, Sang-Yeub Lee, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee, Kyung Pyo Hong, Jeong Euy Park, Hyeon-Cheol Gwon. (2011) Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era. Heart and Vessels
CrossRef104
Michael J. Mack. (2011) Coronary artery disease: How should the STICH trial results affect clinical practice?. Nature Reviews Cardiology 8:8, 427-428
CrossRef105
David J. Maron, William E. Boden, John A. Spertus, Pamela M. Hartigan, G.B. John Mancini, Steven P. Sedlis, William J. Kostuk, Bernard R. Chaitman, Leslee J. Shaw, Daniel S. Berman, Marcin Dada, Koon K. Teo, William S. Weintraub, Robert A. O'Rourke. (2011) Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial. Journal of the American College of Cardiology 58:2, 131-137
CrossRef106
Hisato Takagi, Takuya Umemoto. (2011) Percutaneous coronary intervention versus medical therapy for stable coronary artery disease: Meta-regression analysis of mortality and morbidity against stent use. International Journal of Cardiology 150:1, 90-92
CrossRef107
S. P. Fitzgerald. (2011) Invasive versus non-invasive coronary angiography. Internal Medicine Journal 41:7, 582-583
CrossRef108
H.- J. Priebe. (2011) Preoperative cardiac management of the patient for non-cardiac surgery: an individualized and evidence-based approach. British Journal of Anaesthesia 107:1, 83-96
CrossRef109
Tomofumi Misaka, Hiroyuki Kunii, Hiroyuki Mizukami, Nobuo Sakamoto, Kazuhiko Nakazato, Yasuchika Takeishi. (2011) Long-term clinical outcomes after deferral of percutaneous coronary intervention of intermediate coronary stenoses based on coronary pressure-derived fractional flow reserve. Journal of Cardiology 58:1, 32-37
CrossRef110
Carlos Falces, Rut Andrea, Magda Heras, Cristina Vehí, Marta Sorribes, Laura Sanchis, Joaquim Cevallos, Ignacio Menacho, Sílvia Porcar, David Font, Manel Sabaté, Josep Brugada. (2011) Integración entre cardiología y atención primaria: impacto sobre la práctica clínica. Revista Española de Cardiología 64:7, 564-571
CrossRef111
Francesco Borgia, Nicola Viceconte, Omar Ali, Claire Stuart-Buttle, Anjana Saraswathyamma, Rosario Parisi, Francesca Mirabella, Konstantinos Dimopoulos, Carlo Di Mario. (2011) Improved cardiac survival, freedom from mace and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions. International Journal of Cardiology
CrossRef112
Marc I. Chimowitz, Michael J. Lynn, Tanya N. Turan, David Fiorella, Bethany F. Lane, Scott Janis, Colin P. Derdeyn. (2011) Design of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Journal of Stroke and Cerebrovascular Diseases 20:4, 357-368
CrossRef113
Carlos Falces, Rut Andrea, Magda Heras, Cristina Vehí, Marta Sorribes, Laura Sanchis, Joaquim Cevallos, Ignacio Menacho, Sílvia Porcar, David Font, Manel Sabaté, Josep Brugada. (2011) Integration Between Cardiology and Primary Care: Impact on Clinical Practice. Revista Española de Cardiología (English Edition) 64:7, 564-571
CrossRef114
Samuel A. Daneshvar, Shahbudin H. Rahimtoola. (2011) CT Angiography for All Patients With Inconclusive Noninvasive Test? Clinical Perspective: “Not Yet”. JACC: Cardiovascular Imaging 4:7, 752-753
CrossRef115
Joshua Lehrer, William F. Fearon. 2011. Stable Angina. , 33-42.
CrossRef116
Myriam Moret, Philippe Moulin. (2011) Dépistage de l’ischémie myocardique silencieuse des patients diabétiques : modalités et enjeux. La Presse Médicale 40:6, 625-633
CrossRef117
Deepak P. Chandrasekharan, David P. Taggart. (2011) Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. European Journal of Cardio-Thoracic Surgery 39:6, 912-917
CrossRef118
Carl L. Tommaso. (2011) Effect of PCI on quality of life: “Good always triumphs”. Catheterization and Cardiovascular Interventions 77:7, 961-961
CrossRef119
Tarek AN Ahmed, Ioannis Karalis, J Wouter Jukema. (2011) Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises. Expert Opinion on Emerging Drugs 16:2, 203-233
CrossRef120
M. Noutsias, B. Maisch. (2011) Treatment of cardiovascular diseases in cancer patients. Herz 36:4, 340-345
CrossRef121
Therese M Heinonen, Donald M Black. (2011) New considerations in the design of clinical trials for anti-atherosclerotic drugs. Clinical Investigation 1:6, 795-803
CrossRef122
Gerald S Werner. (2011) Outcomes following successful recanalization of chronic total coronary occlusions. Interventional Cardiology 3:3, 391-405
CrossRef123
João L. Cavalcante, Balajii Tamarappoo, Rory Hachamovitch. (2011) Assessing Risk and Predicting Outcomes in Coronary Artery Disease: Physiology, Anatomy, or Biology?. Current Cardiovascular Imaging Reports 4:3, 180-189
CrossRef124
Alexandre S. de Quadros, Tatiane C. Lima, Ana Paula da Rosa Rodrigues, Thais B. Modkovski, Dulce I. Welter, Rogério Sarmento-Leite, Carlos A.M. Gottschall. (2011) Quality of life and health status after percutaneous coronary intervention in stable angina patients. Catheterization and Cardiovascular Interventions 77:7, 954-960
CrossRef125
(2011) CardioPulse Articles * Women's heart health: the focus of this issue * Portrait of C. Noel Bairey Merz, MD, FACC, FAHA * The development of novel cardiovascular therapies for the future * Development of cardiology research in Japan * Personal experience of emigre cardiologist Cihan Cevik, MD, FESC * From the heart of Istanbul to the Texas Heart Institute * Portrait of National Cardiology and Society: Iceland * Cardiologists on this island in the North Atlantic between Europe and the USA, draw on the best from both cultures for their small population * People's corner: Awards * People's corner: In Memorium. European Heart Journal 32:11, 1301-1310
CrossRef126
Shigeo Horinaka. (2011) Use of Nicorandil in Cardiovascular Disease and Its Optimization. Drugs 71:9, 1105-1119
CrossRef127
R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Theodore G. Ganiats, Hani Jneid, A. Michael Lincoff, Eric D. Peterson, George J. Philippides, Pierre Theroux, Nanette K. Wenger, James Patrick Zidar. (2011) 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 57:19, e215-e367
CrossRef128
Paul Schoenhagen, Rory Hachamovitch, Stephan Achenbach. (2011) Coronary CT Angiography and Comparative Effectiveness Research. JACC: Cardiovascular Imaging 4:5, 492-495
CrossRef129
Flavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, Giacomo Boccuzzi, Patrizia Presbitero, Gabriele Pesarini, Valeria Ferrero, Anna S. Ghini, Ramadan Abukaresh, Cristina Aurigemma, Leonardo De Luca, Dennis Zavalloni, Daniela Soregaroli, Paolo Marino, Roberto Garbo, Luisa Zanolla, Corrado Vassanelli. (2011) Immunosuppressive Therapy with Oral Prednisone to Prevent Restenosis after PCI. A Multicenter Randomized Trial. The American Journal of Medicine 124:5, 434-443
CrossRef130
Alexander Kulik, William H. Shrank, Raisa Levin, Niteesh K. Choudhry. (2011) Adherence to Statin Therapy in Elderly Patients After Hospitalization for Coronary Revascularization. The American Journal of Cardiology 107:10, 1409-1414
CrossRef131
Gunver Sophia Kienle, Hans-Ulrich Albonico, Lorenz Fischer, Martin Frei-Erb, Harald J. Hamre, Peter Heusser, Peter F. Matthiessen, Adrian Renfer, Helmut Kiene. (2011) Complementary Therapy Systems and Their Integrative Evaluation. EXPLORE: The Journal of Science and Healing 7:3, 175-187
CrossRef132
Olaf Schulz, Markus Reinicke, Jochen Krämer, Gunnar Berghöfer, Ricarda Bensch, Ingolf Schimke, Allan Jaffe. (2011) Pregnancy-associated plasma protein A values in patients with stable cardiovascular disease: Use of a new monoclonal antibody-based assay. Clinica Chimica Acta 412:11-12, 880-886
CrossRef133
Zoltán Vokó, Sophie Brouwer, Jacobus Lubsen, Nicolas Danchin, Jan-Erik Otterstad, Peter H. J. M. Dunselman, Bridget-Anne Kirwan. (2011) Long-term impact of secondary preventive treatments in patients with stable angina. European Journal of Epidemiology 26:5, 375-383
CrossRef134
Shuichi Hamasaki, Chuwa Tei. (2011) Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. Journal of Cardiology 57:3, 231-238
CrossRef135
Oliver Gaemperli, Philipp A. Kaufmann. (2011) Kardiale Hybridbildgebung. Clinical Research in Cardiology Supplements 6:S1, 32-42
CrossRef136
Emil M. deGoma, Daniel J. Rader. (2011) Novel HDL-directed pharmacotherapeutic strategies. Nature Reviews Cardiology 8:5, 266-277
CrossRef137
Amitabh Chandra, Anupam B Jena, Jonathan S Skinner. (2011) The Pragmatist's Guide to Comparative Effectiveness Research. Journal of Economic Perspectives 25:2, 27-46
CrossRef138
Bryan P. Yan, Andrew E. Ajani, David J. Clark. 2011. Approach to Multivessel Coronary Artery Disease. , 312-321.
CrossRef139
Neil Swanson, Anthony Gershlick. 2011. Primary and Rescue PCI in Acute Myocardial Infarction. , 242-261.
CrossRef140
Abhiram Prasad, Bernard J. Gersh. 2011. Stable Angina. , 213-231.
CrossRef141
Peter Langguth, Joachim Seydel. (2011) Überarbeitetes Glossar zu Begriffen der Pharmazeutik. Angewandte Chemie 123:15, 3635-3651
CrossRef142
R. Hachamovitch, A. Rozanski, L. J. Shaw, G. W. Stone, L. E. J. Thomson, J. D. Friedman, S. W. Hayes, I. Cohen, G. Germano, D. S. Berman. (2011) Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. European Heart Journal 32:8, 1012-1024
CrossRef143
Stephen G. Ellis, Mehdi H. Shishehbor, Samir R. Kapadia, A. Michael Lincoff, Ravi Nair, Patrick L. Whitlow, Christopher T. Bajzer, Leslie L. Cho, E. Murat Tuzcu, Russell Raymond, Patrick Vargo, Rebecca Cunningham, Sandra J. Dushman-Ellis. (2011) Enhanced Prediction of Mortality After Percutaneous Coronary Intervention by Consideration of General and Neurological Indicators. JACC: Cardiovascular Interventions 4:4, 442-448
CrossRef144
Philippe Kolh, William Wijns. (2011) Joint ESC/EACTS guidelines on myocardial revascularization. Journal of Cardiovascular Medicine 12:4, 264-267
CrossRef145
Clara Carpeggiani, Patrizia Landi, Claudio Michelassi, Elena Barberini, Antonio L'Abbate. (2011) Long-term prognosis in stable angina; medical treatment or coronary revascularization in patients younger than 70years?. International Journal of Cardiology 148:1, 43-47
CrossRef146
L. Björck, S. Capewell, K. Bennett, G. Lappas, A. Rosengren. (2011) Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains. Journal of Internal Medicine 269:4, 452-467
CrossRef147
Stefano Sdringola, Nils P. Johnson, Richard L. Kirkeeide, Emma Cid, K. Lance Gould. (2011) Impact of Unexpected Factors on Quantitative Myocardial Perfusion and Coronary Flow Reserve in Young, Asymptomatic Volunteers. JACC: Cardiovascular Imaging 4:4, 402-412
CrossRef148
ALEXIS A. D’ELIA, ABDUL MOIZ HAFIZ, SRIHARI S. NAIDU, KEVIN P. MARZO. (2011) Patient Awareness of Stent Type, Risk of Cardiac Events, and Symptoms of Myocardial Infarction Among PCI patients: A Missed Educational Opportunity?. Journal of Interventional Cardiology 24:2, 144-148
CrossRef149
Deepika S. Reddy, Vivian Fonseca. 2011. Screening Patients with Prediabetes and Diabetes for Cardiovascular Disease. , 34-40.
CrossRef150
Stephen H. Mckellar, Morgan L. Brown, Robert L. Frye. 2011. Is there an Optimal Revascularization Strategy in Diabetic Patients with Ischemic Heart Disease?. , 145-152.
CrossRef151
Thomas Schachner, Nikolaos Bonaros, Dominik Wiedemann, Eric J. Lehr, Felix Weidinger, Gudrun Feuchtner, David Zimrin, Johannes Bonatti. (2011) Predictors, Causes, and Consequences of Conversions in Robotically Enhanced Totally Endoscopic Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery 91:3, 647-653
CrossRef152
Catherine Norton, Vasiliki Georgiopoulou, Andreas Kalogeropoulos, Javed Butler. (2011) Chronic stable angina: pathophysiology and innovations in treatment. Journal of Cardiovascular Medicine 12:3, 218-219
CrossRef153
M. MAUFUS, J. B. GUITTON, G. VANZETTO, L. BELLE, B. IMBERT, G. PERNOD. (2011) Prognostic value of the ankle-brachial index in patients with stable chronic cardiovascular disease. Journal of Thrombosis and Haemostasis 9:3, 610-612
CrossRef154
P. Gosse. (2011) Après Star et Astral, revenons sur terre !. Journal de Radiologie 92:3, 186-187
CrossRef155
Claude Le Feuvre, Sophie Jacqueminet, Olivier Barthelemy. (2011) Myocardial ischemia: a silent epidemic in Type 2 diabetes patients. Future Cardiology 7:2, 183-190
CrossRef156
Dieter Horstkotte, Marcus Wiemer, Frank Buuren. (2011) Performance figures of invasive cardiology in Germany 2006 and 2007 focussing on coronary artery disease. Clinical Research in Cardiology 100:3, 187-190
CrossRef157
Sherry L. Grace, Caroline Chessex, Heather Arthur, Sammy Chan, Cleo Cyr, William Dafoe, Martin Juneau, Paul Oh, Neville Suskin. (2011) Systematizing Inpatient Referral to Cardiac Rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society Joint Position Paper. Canadian Journal of Cardiology 27:2, 192-199
CrossRef158
Doralisa Morrone, William S. Weintraub. (2011) Interventional cardiology: Cost-effectiveness of PCI guided by fractional flow reserve. Nature Reviews Cardiology 8:3, 125-126
CrossRef159
Salvatore Brugaletta, Hector M. Garcia-Garcia, Zhu Jun Shen, Josep Gomez-Lara, Roberto Diletti, Giovanna Sarno, Nieves Gonzalo, William Wijns, Bernard Bruyne, Fernando Alfonso, Patrick W. Serruys. (2011) Morphology of coronary artery lesions assessed by virtual histology intravascular ultrasound tissue characterization and fractional flow reserve. The International Journal of Cardiovascular Imaging
CrossRef160
2011. Management of Inpatient Diabetes. , 47-63.
CrossRef161
Joel A. Lardizabal, Prakash C. Deedwania. (2011) The Anti-Ischemic and Anti-Anginal Properties of Statins. Current Atherosclerosis Reports 13:1, 43-50
CrossRef162
Serafina Valente, Chiara Lazzeri, Marco Chiostri, Lusinda Osmanagaj, Cristina Giglioli, Gian Franco Gensini. (2011) STEMI Patients-The More You Bleed, the More You Die: A Comparison Between Classifications. Clinical Cardiology 34:2, 90-96
CrossRef163
David J. Maron, William E. Boden, William S. Weintraub, Karen J. Calfas, Robert A. O’Rourke. (2011) Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?. Current Treatment Options in Cardiovascular Medicine 13:1, 16-25
CrossRef164
Robert C. Hendel, Brian G. Abbott, Timothy M. Bateman, Ron Blankstein, Dennis A. Calnon, Jeffrey A. Leppo, Jamshid Maddahi, Matthew M. Schumaecker, Leslee J. Shaw, R. Parker Ward, David G. Wolinsky. (2011) The role of radionuclide myocardial perfusion imaging for asymptomatic individuals. Journal of Nuclear Cardiology 18:1, 3-15
CrossRef165
Robert Hendel, Naim Dahdah. (2011) The potential role for the use of cardiac computed tomography angiography for the acute chest pain patient in the emergency department: A cautionary viewpoint. Journal of Nuclear Cardiology 18:1, 163-167
CrossRef166
Tracy Y. Wang, Antonio Gutierrez, Eric D. Peterson. (2011) Percutaneous coronary intervention in the elderly. Nature Reviews Cardiology 8:2, 79-90
CrossRef167
Enrico Ammirati, Ornella E. Rimoldi, Paolo G. Camici. (2011) Is There Evidence Supporting Coronary Revascularization in Patients With Left Ventricular Systolic Dysfunction?. Circulation Journal 75:1, 3-10
CrossRef168
Guenter Pilz, Pankaj A. Patel, Ulrich Fell, Joseph A. Ladapo, John A. Rizzo, Hai Fang, Candace Gunnarsson, Tobias Heer, Berthold Hoefling. (2011) Adenosine-stress cardiac magnetic resonance imaging in suspected coronary artery disease: a net cost analysis and reimbursement implications. The International Journal of Cardiovascular Imaging 27:1, 113-121
CrossRef169
Masato Nakamura. (2011) Angiography Is the Gold Standard and Objective Evidence of Myocardial Ischemia Is Mandatory If Lesion Severity Is Questionable. Circulation Journal 75:1, 204-210
CrossRef170
Ezequiel H Forte, Maria G Rousse, Jorge A Lowenstein. (2011) Target heart rate to determine the normal value of coronary flow reserve during dobutamine stress echocardiography. Cardiovascular Ultrasound 9:1, 10
CrossRef171
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Frederick G. Kushner, E. Magnus Ohman, William Stevenson, Clyde W. Yancy. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef172
Fiona M Clement, William A Ghali, Stephane Rinfret, Braden J Manns, . (2011) Economic evaluation of increasing population rates of cardiac catheterization. BMC Health Services Research 11:1, 324
CrossRef173
Rolf Gebker, Cosima Jahnke, Robert Manka, Thomas Hucko, Bernhard Schnackenburg, Sebastian Kelle, Christoph Klein, Eckart Fleck, Ingo Paetsch. (2011) The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease. Journal of Cardiovascular Magnetic Resonance 13:1, 46
CrossRef174
Keiichiro Yoshinaga, Osamu Manabe, Nagara Tamaki. (2011) Physiological Assessment of Myocardial Perfusion Using Nuclear Cardiology Would Enhance Coronary Artery Disease Patient Care. Circulation Journal 75:3, 713-723
CrossRef175
Kenichi Nakajima, Shinro Matsuo, Koichi Okuda, Hiroshi Wakabayashi, Kazumasa Tsukamoto, Tsunehiko Nishimura. (2011) Estimation of Cardiac Event Risk by Gated Myocardial Perfusion Imaging and Quantitative Scoring Methods Based on a Multi-Center J-ACCESS Database. Circulation Journal 75:10, 2417-2423
CrossRef176
Seung-Whan Lee, Jong-Young Lee, Duk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, Won-Jang Kim, Jon Suh, Yoon Hang Cho, Nae-Hee Lee, Soo-Jin Kang, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park. (2011) Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef177
Jonathan Skinner. 2011. Causes and Consequences of Regional Variations in Health Care. , 45-93.
CrossRef178
Nahush A. Mokadam, Ryland E. Melford Jr., Charles Maynard, John R. Goss, Douglas Stewart, Mark Reisman, Gabriel S. Aldea. (2011) Prevalence and Procedural Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in Patients with Diabetes and Multivessel Coronary Artery Disease. Journal of Cardiac Surgery 26:1, 1-8
CrossRef179
Paul Schoenhagen, Kiyoko Uno. (2011) Coronary Computed Tomography in the Evaluation of Symptomatic Patients With Suspected Coronary Artery Disease. Circulation Journal 75:10, 2320-2321
CrossRef180
G. Ganesha Babu, J. Malcolm Walker, D. M. Yellon, D. J. Hausenloy. (2011) Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. European Heart Journal 32:1, 23-31
CrossRef181
Fiona M Clement, Braden J Manns, Brenda Brownell, Peter D Faris, Michelle M Graham, Karin Humphries, Michael Love, Merril L Knudtson, William A Ghali, . (2011) A multi-region assessment of population rates of cardiac catheterization and yield of high-risk coronary artery disease. BMC Health Services Research 11:1, 323
CrossRef182
Amitabh Chandra, David Cutler, Zirui Song. 2011. Who Ordered That? The Economics of Treatment Choices in Medical Care. , 397-432.
CrossRef183
, Albert Flotats, Juhani Knuuti, Matthias Gutberlet, Claudio Marcassa, Frank M. Bengel, Philippe A. Kaufmann, Michael R. Rees, Birger Hesse. (2011) Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). European Journal of Nuclear Medicine and Molecular Imaging 38:1, 201-212
CrossRef184
M.-F. Seronde, F. Schiele. (2011) Les événements coronariens aigus après angioplastie coronaire : quels sont les bénéfices de l’angioplastie dans l’angor stable ?. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2011:194, 27-30
CrossRef185
Takashi Akasaka. (2011) What Can We Expect in PCI in Patients With Chronic Coronary Artery Disease. Circulation Journal 75:1, 211-217
CrossRef186
Luc Lorgis, Carole Richard, Aurélie Gudjoncik, Marianne Zeller, Philippe Buffet, Isabelle L’Huillier, Yves Cottin. (2011) L’association inhibiteur de l’enzyme de conversion et antagoniste calcique. Quelle place chez le patient coronarien stable ?. Thérapie 66:1, 17-24
CrossRef187
H L Elliott, P A Meredith. (2011) Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the ‘ACTION’ database in patients with angina. Journal of Human Hypertension 25:1, 63-70
CrossRef188
Nico H.J. Pijls, Pim A.L. Tonino. (2011) Reply. Journal of the American College of Cardiology 57:1, 116
CrossRef189
Byung-Hee Hwang, Myung-Hee Kim, Kiyuk Chang. (2011) Molecular Imaging of High-Risk Atherosclerotic Plaques: Is It Clinically Translatable?. Korean Circulation Journal 41:9, 497
CrossRef190
Nikolaos Pagonas, Wolfgang Utz, Jeanette Schulz-Menger, Andreas Busjahn, Jan Monti, Ludwig Thierfelder, Rainer Dietz, Volker Klauss, Michael Gross, Ivo R. Buschmann, Eva-Elina Buschmann. (2010) Assessment of the effect of external counterpulsation on myocardial adaptive arteriogenesis by invasive functional measurements — design of the arteriogenesis network trial 2. International Journal of Cardiology 145:3, 432-437
CrossRef191
S. Jacqueminet, O. Barthelemy, F. Rouzet, R. Isnard, M. Halbron, A. Bouzamondo, D. Le Guludec, A. Grimaldi, J.-P. Metzger, C. Le Feuvre. (2010) A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patients. Diabetes & Metabolism 36:6, 463-469
CrossRef192
Mario Marzilli, Alda Huqi, Doralisa Morrone. (2010) Persistent Angina. American Journal Cardiovascular Drugs 10, 27-32
CrossRef193
Graciana Ciambrone, Juan Carlos Kaski. (2010) Gender differences in the treatment of chronic ischemic heart disease: prognostic implications. Fundamental & Clinical Pharmacology 24:6, 707-710
CrossRef194
Stefano Muzzarelli, Matthias Emil Pfisterer, Jan Müller-Brand, Michael Johannes Zellweger. (2010) Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification. The International Journal of Cardiovascular Imaging 26:8, 871-879
CrossRef195
Sean A. Enkiri, Angela M. Taylor, Ellen C. Keeley, Lewis C. Lipson, Lawrence W. Gimple, Michael Ragosta. (2010) Coronary angiography is a better predictor of mortality than noninvasive testing in patients evaluated for renal transplantation. Catheterization and Cardiovascular Interventions 76:6, 795-801
CrossRef196
Stanley F. Fernandez, William E. Boden. (2010) Strategies in Stable Ischemic Heart Disease: Lessons from the COURAGE and BARI-2D Trials. Current Atherosclerosis Reports 12:6, 423-431
CrossRef197
Elizabeth M. Holper, Tayo Addo. (2010) Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention. Coronary Artery Disease 21:7, 397-401
CrossRef198
Arthur E. Fass. (2010) Chronic Coronary Disease in the Post-COURAGE Era. Cardiology in Review 18:6, 292-297
CrossRef199
Daniel S. Menees, Eric R. Bates. (2010) Evaluation of patients with suspected coronary artery disease. Coronary Artery Disease 21:7, 386-390
CrossRef200
Ansar Hassan, Alice Newman, Dennis T. Ko, Stéphane Rinfret, Gregory Hirsch, William A. Ghali, Jack V. Tu. (2010) Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005. American Heart Journal 160:5, 958-965
CrossRef201
Carlo Di Mario. (2010) The Show is Over: time to start preparing the new one. EuroIntervention 6:5, 555-559
CrossRef202
Lewis H. Kuller. (2010) Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease. Coronary Artery Disease 21:7, 391-396
CrossRef203
Maria Mori Brooks, William E. Boden, Robert L. Frye. (2010) Clinical implications of the BARI 2D and COURAGE trials: overview. Coronary Artery Disease 21:7, 383-385
CrossRef204
Giuseppe Tarantini, Davide Lanzellotti. (2010) Three-vessel coronary disease in diabetics: personalized versus evidence-based revascularization strategy. Future Cardiology 6:6, 797-809
CrossRef205
Kevin L. Greason, Hartzell V. Schaff. (2010) Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved. Coronary Artery Disease 21:7, 402-406
CrossRef206
Andrew Friedrich, Tarek Helmy. (2010) Prevention of Perioperative Myocardial Infarction. International Anesthesiology Clinics 47:4, 13-36
CrossRef207
Anna L. Waterbrook, John C. Southall, Tania D. Strout, Michael R. Baumann. (2010) The Knowledge and Usage of Complementary and Alternative Medicine by Emergency Department Patients and Physicians. The Journal of Emergency Medicine 39:5, 569-575
CrossRef208
Raffaele Giubbini, Francesco Bertagna. (2010) Comparison of diagnostic performances of three different software packages in detecting coronary artery disease. European Journal of Nuclear Medicine and Molecular Imaging 37:11, 2068-2069
CrossRef209
, , W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M. F. Piepoli, C. Pirlet, J. L. Pomar, N. Reifart, F. L. Ribichini, M. J. Schalij, P. Sergeant, P. W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. E. Vardas, P. Widimsky, , P. Kolh, O. Alfieri, J. Dunning, S. Elia, P. Kappetein, U. Lockowandt, G. Sarris, P. Vouhe, , P. Kearney, L. von Segesser, S. Agewall, A. Aladashvili, D. Alexopoulos, M. J. Antunes, E. Atalar, A. Brutel de la Riviere, A. Doganov, J. Eha, J. Fajadet, R. Ferreira, J. Garot, J. Halcox, Y. Hasin, S. Janssens, K. Kervinen, G. Laufer, V. Legrand, S. A. M. Nashef, F.-J. Neumann, K. Niemela, P. Nihoyannopoulos, M. Noc, J. J. Piek, J. Pirk, Y. Rozenman, M. Sabate, R. Starc, M. Thielmann, D. J. Wheatley, S. Windecker, M. Zembala. (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 31:20, 2501-2555
CrossRef210
Sundeep Chaudhry, Ross A. Arena, James E. Hansen, Gregory D. Lewis, Jonathan N. Myers, Laurence S. Sperling, Brian D. LaBudde, Karlman Wasserman. (2010) The Utility of Cardiopulmonary Exercise Testing to Detect and Track Early-Stage Ischemic Heart Disease. Mayo Clinic Proceedings 85:10, 928-932
CrossRef211
Edward M. Hsiao, Bilal Ali, Sharmila Dorbala. (2010) Clinical Role of Hybrid Imaging. Current Cardiovascular Imaging Reports 3:5, 324-335
CrossRef212
Grigorios Korosoglou, Yacine Elhmidi, Henning Steen, Dieter Schellberg, Nina Riedle, Johannes Ahrens, Stephanie Lehrke, Constanze Merten, Dirk Lossnitzer, Jannis Radeleff, Christian Zugck, Evangelos Giannitsis, Hugo A. Katus. (2010) Prognostic Value of High-Dose Dobutamine Stress Magnetic Resonance Imaging in 1,493 Consecutive Patients. Journal of the American College of Cardiology 56:15, 1225-1234
CrossRef213
Chiara Lazzeri, Serafina Valente, Marco Chiostri, Claudio PIcariello, Gian F Gensini. (2010) Microalbuminuria in hypertensive nondiabetic patients with ST elevation myocardial infarction. Journal of Cardiovascular Medicine 11:10, 748-753
CrossRef214
Dave Nellesen, Howard G. Birnbaum, Paul E. Greenberg. (2010) Perspectives on Comparative Effectiveness Research. PharmacoEconomics 28:10, 789-798
CrossRef215
G. Morton, A. Schuster, D. Perera, E. Nagel. (2010) Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease. European Heart Journal 31:18, 2209-2215
CrossRef216
A. Hiebel, A. Fagot-Campagna, S. Fosse, M. Varroud-Vial, A. Weill, A. Penfornis. (2010) Feasibility of screening for silent myocardial ischaemia according to the ALFEDIAM–SFC 2004 Guidelines in a population of diabetic patients. Diabetes & Metabolism 36:4, 286-292
CrossRef217
Pierre Amarenco, Julien Labreuche, Mikael Mazighi. (2010) Lessons from carotid endarterectomy and stenting trials. The Lancet 376:9746, 1028-1031
CrossRef218
K. Lance Gould, Nils P. Johnson. (2010) Coronary artery disease: Percent stenosis in CAD—a flaw in current practice. Nature Reviews Cardiology 7:9, 482-484
CrossRef219
Chim C. Lang, Sandeep Gupta, Paul Kalra, Bernard Keavney, Ian Menown, Chris Morley, Sandosh Padmanabhan. (2010) Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: Clinical evidence and pathophysiological mechanisms. Atherosclerosis 212:1, 1-8
CrossRef220
Peter H. Stone, Bernard R. Chaitman, Karen Stocke, Junko Sano, Arthur DeVault, Gary G. Koch. (2010) The Anti-Ischemic Mechanism of Action of Ranolazine in Stable Ischemic Heart Disease. Journal of the American College of Cardiology 56:12, 934-942
CrossRef221
Pradeep K Nair, Suresh R Mulukutla, Oscar C Marroquin. (2010) Stents and statins: history, clinical outcomes and mechanisms. Expert Review of Cardiovascular Therapy 8:9, 1283-1295
CrossRef222
Ronald J. Krone. (2010) Managing Coronary Artery Disease in the Cancer Patient. Progress in Cardiovascular Diseases 53:2, 149-156
CrossRef223
Thomas Münzel, Eberhard Schulz. (2010) Therapie der koronaren Herzerkrankung mit NO-Donatoren. Nach wie vor eine wichtige Option. Pharmazie in unserer Zeit 39:5, 359-368
CrossRef224
Moutaz El-Kadri, Hala Sharaf-Dabbagh, David Ramsdale. (2010) REVIEW: Role of Antiischemic Agents in the Management of Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS). Cardiovascular Therapeuticsno-no
CrossRef225
Michael S. Lauer. (2010) The historical and moral imperatives of comparative effectiveness research. Statistics in Medicine 29:19, 1982-1984
CrossRef226
D Moher. (2010) CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (Chinese version). Journal of Chinese Integrative Medicine701-741
CrossRef227
Rolf Ekroth, Elisabeth ståhle. (2010) High or low risk coronary patients – who gets the highest priority?. Scandinavian Cardiovascular Journal 44:4, 195-196
CrossRef228
David V. Daniels, William F. Fearon. (2010) Fractional Flow Reserve: A Practical Update. Current Cardiovascular Imaging Reports 3:4, 215-221
CrossRef229
David Moher, Sally Hopewell, Kenneth F. Schulz, Victor Montori, Peter C. Gøtzsche, P.J. Devereaux, Diana Elbourne, Matthias Egger, Douglas G. Altman. (2010) CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology 63:8, e1-e37
CrossRef230
Loren F. Hiratzka, George L. Bakris, Joshua A. Beckman, Robert M. Bersin, Vincent F. Carr, Donald E. Casey, Kim A. Eagle, Luke K. Hermann, Eric M. Isselbacher, Ella A. Kazerooni, Nicholas T. Kouchoukos, Bruce W. Lytle, Dianna M. Milewicz, David L. Reich, Souvik Sen, Julie A. Shinn, Lars G. Svensson, David M. Williams, Alice K. Jacobs, Sidney C. Smith, Jeffery L. Anderson, Cynthia D. Adams, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick Nishimura, Richard L. Page, Barbara Riegel, William G. Stevenson, Lynn G. Tarkington, Clyde W. Yancy. (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary. Catheterization and Cardiovascular Interventions 76:2, E43-E86
CrossRef231
Carlo Di Mario, Jose Zamorano. (2010) Hand and brain: interventional cardiology and echocardiography. EuroIntervention 6:3, 309-312
CrossRef232
Chang-Wook Nam, Hyuck-Jun Yoon, Yun-Kyeong Cho, Hyoung-Seob Park, Hyungseop Kim, Seung-Ho Hur, Yoon-Nyun Kim, In-Sung Chung, Bon-Kwon Koo, Seung-Jae Tahk, William F. Fearon, Kwon-Bae Kim. (2010) Outcomes of Percutaneous Coronary Intervention in Intermediate Coronary Artery Disease. JACC: Cardiovascular Interventions 3:8, 812-817
CrossRef233
J.-C. Tardif. (2010) Coronary artery disease in 2010. European Heart Journal Supplements 12:Suppl C, C2-C10
CrossRef234
Shuchita Gupta, Gregg S. Pressman, D. Lynn Morris, Vincent M. Figueredo. (2010) Distribution of left ventricular ejection fraction in angina patients with severe coronary artery disease not amenable to revascularization. Coronary Artery Disease 21:5, 278-280
CrossRef235
Jacob Cross Townsend, David Gregg. (2010) Cardiac Computed Tomography and Magnetic Resonance Imaging. Journal of Thoracic Imaging 25:3, 194-203
CrossRef236
Elias B. Hanna, Thomas A. Hennebry. (2010) Periprocedural Myocardial Infarction: Review and Classification. Clinical Cardiology 33:8, 476-483
CrossRef237
Carolyn M. Taylor, Karin H. Humphries, Aihua Pu, William Ghali, Min Gao, Merril Knudtson, Udo Hoffmann, Ronald G. Carere. (2010) A Proposed Clinical Model for Efficient Utilization of Invasive Coronary Angiography. The American Journal of Cardiology 106:4, 457-462
CrossRef238
Chiara Lazzeri, Serafina Valente, Marco Chiostri, Claudio Picariello, Gian Franco Gensini. (2010) Evaluation of acid–base balance in ST-elevation myocardial infarction in the early phase: a prognostic tool?. Coronary Artery Disease 21:5, 266-272
CrossRef239
R.P.J. Budde, F. Huo, M.J.M. Cramer, P.A.F.M. Doevendans, M.L. Bots, F.L. Moll, M. Prokop. (2010) Simultaneous Aortic and Coronary Assessment in Abdominal Aortic Aneurysm Patients by Thoraco-abdominal 64-Detector-row CT Angiography: Estimate of the Impact on Preoperative Management: A Pilot Study. European Journal of Vascular and Endovascular Surgery 40:2, 196-201
CrossRef240
Siu-Sun Yao, Sripal Bangalore, Farooq A. Chaudhry. (2010) Prognostic Implications of Stress Echocardiography and Impact on Patient Outcomes: An Effective Gatekeeper for Coronary Angiography and Revascularization. Journal of the American Society of Echocardiography 23:8, 832-839
CrossRef241
Robert A. O'Rourke. (2010) Alternative Strategies for the Management of Chronic Stable Angina. Current Problems in Cardiology 35:8, 384-446
CrossRef242
Chiara Lazzeri, Serafina Valente, Marco Chiostri, Claudio Picariello, Gian Franco Gensini. (2010) In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes. European Journal of Cardiovascular Prevention & Rehabilitation 17:4, 419-423
CrossRef243
Cathy Jeon, Susana C. Candia, John C. Wang, Elizabeth M. Holper, Michelle Ammerer, Richard E. Kuntz, Laura Mauri. (2010) Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: A model for protection from acute myocardial infarction. American Heart Journal 160:1, 195-201
CrossRef244
John P. A. Ioannidis. (2010) Meta-research: The art of getting it wrong. Research Synthesis Methods 1:3-4, 169-184
CrossRef245
Gerard Devlin. (2010) Women and elderly: subgroups under-represented in clinical trials. Current Opinion in Cardiology 25:4, 335-339
CrossRef246
Elisabeth Arnoldi, Thomas Henzler, Gorka Bastarrika, Christian Thilo, Konstantin Nikolaou, U. Joseph Schoepf. (2010) Evaluation of Plaques and Stenosis. Radiologic Clinics of North America 48:4, 729-744
CrossRef247
Giuseppe Biondi-Zoccai, Claudio Moretti, Antonio Abbate, Imad Sheiban. (2010) Percutaneous coronary intervention for small vessel coronary artery disease. Cardiovascular Revascularization Medicine 11:3, 189-198
CrossRef248
Dominique Joyal, Jonathan Afilalo, Stéphane Rinfret. (2010) Effectiveness of recanalization of chronic total occlusions: A systematic review and meta-analysis. American Heart Journal 160:1, 179-187
CrossRef249
Nico H.J. Pijls, William F. Fearon, Pim A.L. Tonino, Uwe Siebert, Fumiaki Ikeno, Bernhard Bornschein, Marcel van't Veer, Volker Klauss, Ganesh Manoharan, Thomas Engstrøm, Keith G. Oldroyd, Peter N. Ver Lee, Philip A. MacCarthy, Bernard De Bruyne. (2010) Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease. Journal of the American College of Cardiology 56:3, 177-184
CrossRef250
Nanette K. Wenger. (2010) Angina in Women. Current Cardiology Reports 12:4, 307-314
CrossRef251
Sachin A Shah, Robert J Shapiro, Rina Mehta, Jeffrey A Snyder. (2010) Impact of Enhanced External Counterpulsation on Canadian Cardiovascular Society Angina Class in Patients with Chronic Stable Angina: A Meta-analysis. Pharmacotherapy 30:7, 639-645
CrossRef252
Cihan Simsek, Yoshinobu Onuma, Michael Magro, Sanneke de Boer, Linda Battes, Ron T. van Domburg, Eric Boersma, Patrick W. Serruys. (2010) Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Catheterization and Cardiovascular Interventions 76:1, 41-49
CrossRef253
John D Horowitz, Yuliy Y Chirkov, Jennifer A Kennedy, Aaron L Sverdlov. (2010) Modulation of myocardial metabolism: an emerging therapeutic principle. Current Opinion in Cardiology 25:4, 329-334
CrossRef254
Robert J. Applegate. (2010) Fractional Flow Reserve-Guided Stent Therapy for Multivessel Disease. Journal of the American College of Cardiology 55:25, 2822-2824
CrossRef255
Terase Lancefield, David J. Clark, Nick Andrianopoulos, Angela L. Brennan, Christopher M. Reid, Jennifer Johns, Melanie Freeman, Kerrie Charter, Stephen J. Duffy, Andrew E. Ajani, Joseph Proietto, Omar Farouque. (2010) Is There an Obesity Paradox After Percutaneous Coronary Intervention in the Contemporary Era?. JACC: Cardiovascular Interventions 3:6, 660-668
CrossRef256
Robert O. Bonow. (2010) 2009 ASNC keynote lecture: Measuring cost, cost-effectiveness, and quality in cardiovascular imaging. Journal of Nuclear Cardiology 17:3, 362-369
CrossRef257
Timothy J. O'Leary, Jean R. Slutsky, Marie A. Bernard. (2010) Comparative Effectiveness Research Priorities at Federal Agencies: The View from the Department of Veterans Affairs, National Institute on Aging, and Agency for Healthcare Research and Quality. Journal of the American Geriatrics Society 58:6, 1187-1192
CrossRef258
Enrico Orsini, Giovanni Battista Zito. (2010) Matching pathophysiology and evidence-based medicine for optimal management of ischemic heart disease. Journal of Cardiovascular Medicine 11:6, 469-476
CrossRef259
Young-Hak Kim, Duk-Woo Park, Won-Jang Kim, Jong-Young Lee, Sung-Cheol Yun, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Myeong-Ki Hong, Seong-Wook Park, Seung-Jung Park. (2010) Impact of the Extent of Coronary Artery Disease on Outcomes After Revascularization for Unprotected Left Main Coronary Artery Stenosis. Journal of the American College of Cardiology 55:23, 2544-2552
CrossRef260
Thomas T Tsai, Brahmahjee K Nallamothu. (2010) Percutaneous coronary intervention in patients with chronic kidney disease: where’s the evidence?. Interventional Cardiology 2:3, 253-256
CrossRef261
Pim A.L. Tonino, William F. Fearon, Bernard De Bruyne, Keith G. Oldroyd, Massoud A. Leesar, Peter N. Ver Lee, Philip A. MacCarthy, Marcel van't Veer, Nico H.J. Pijls. (2010) Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study. Journal of the American College of Cardiology 55:25, 2816-2821
CrossRef262
D. H. J. Elder, M. Pauriah, C. C. Lang, J. Shand, I. B. A. Menown, B. D. W. C. K. Sin, S. Gupta, S. G. Duckett, W. Foster, D. Zachariah, P. R. Kalra. (2010) Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?. QJM 103:5, 305-310
CrossRef263
S. Störk, G. Ertl, S. Nitschmann. (2010) Revaskularisation bei Patienten mit Typ-2-Diabetes und koronarer Herzkrankheit. Der Internist 51:5, 674-676
CrossRef264
Stacey Jolly, Chi Kao, Andrew B. Bindman, Carol Korenbrot. (2010) Cardiac Procedures among American Indians and Alaska Natives compared to Non-Hispanic Whites Hospitalized with Ischemic Heart Disease in California. Journal of General Internal Medicine 25:5, 430-434
CrossRef265
Burton E. Sobel. (2010) Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial. Coronary Artery Disease 21:3, 189-198
CrossRef266
Steven P. Sedlis, William E. Boden. (2010) Percutaneous Revascularization for Stable Coronary Artery Disease. JACC: Cardiovascular Interventions 3:5, 566
CrossRef267
Burton E. Sobel. (2010) A perspective on the development of coronary revascularization. Coronary Artery Disease 21:3, 199-203
CrossRef268
Abhiram Prasad, Anthony Hilliard. (2010) Reply. JACC: Cardiovascular Interventions 3:5, 566-567
CrossRef269
Ran Kornowski. (2010) Refractory myocardial angina and determinants of prognosis. Catheterization and Cardiovascular Interventions 75:6, 892-894
CrossRef270
Kate Goodrich, Patrick H. Conway. (2010) Comparative effectiveness research: Implications for hospital medicine. Journal of Hospital Medicine 5:5, 257-260
CrossRef271
Ethan J. Halpern, David Fischman, Michael P. Savage, Anish R. Koka, Matthew DeCaro, David C. Levin. (2010) Decision Analytic Model for Evaluation of Suspected Coronary Disease with Stress Testing and Coronary CT Angiography. Academic Radiology 17:5, 577-586
CrossRef272
Mauricio G. Cohen, Mario Pascual, Benjamin M. Scirica, E. Magnus Ohman. (2010) Metas terapéuticas en pacientes con angina refractaria crónica. Revista Española de Cardiología 63:5, 571-582
CrossRef273
Mike Seddon, Nick Curzen. (2010) CORONARY REVASCULARISATION IN CHRONIC KIDNEY DISEASE PART 1: STABLE CORONARY ARTERY DISEASE. Journal of Renal Care 36, 106-117
CrossRef274
Sajid Aslam, David Gray. (2010) Ranolazine (Ranexa®) in the treatment of chronic stable angina. Advances in Therapy 27:4, 193-201
CrossRef275
P. Valensi, E. Cosson. (2010) It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes & Metabolism 36:2, 91-96
CrossRef276
Loren F. Hiratzka, George L. Bakris, Joshua A. Beckman, Robert M. Bersin, Vincent F. Carr, Donald E. Casey, Kim A. Eagle, Luke K. Hermann, Eric M. Isselbacher, Ella A. Kazerooni, Nicholas T. Kouchoukos, Bruce W. Lytle, Dianna M. Milewicz, David L. Reich, Souvik Sen, Julie A. Shinn, Lars G. Svensson, David M. Williams. (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease. Journal of the American College of Cardiology 55:14, e27-e129
CrossRef277
George A. Beller. (2010) Compliance with appropriate use criteria for cardiac radionuclide imaging. Journal of Nuclear Cardiology 17:2, 165-167
CrossRef278
Akshay Desai, Frederic S. Resnic. (2010) Highlights from American Heart Association Annual Scientific Sessions 2009: Orlando, Florida, November 14–18, 2009. The Journal of Thoracic and Cardiovascular Surgery 139:4, 1090-1092
CrossRef279
José G. Díez, James M. Wilson. (2010) Practical Strategies for the Management of Anticoagulation Therapy: Unsolved Issues in the Cardiac Catheterization Laboratory. Cardiovascular Drugs and Therapy 24:2, 161-174
CrossRef280
Patrick B. Mark, Rajan K. Patel, Alan G. Jardine. (2010) Screening for Coronary Artery Disease Before Renal Transplantation—Rational or Rationing?. Transplantation 89:7, 807-808
CrossRef281
Manuel D. Cerqueira. (2010) Eighth Annual Mario S. Verani, MD Memorial Lecture: Nuclear cardiology in the era of multimodality cardiac imaging: Can we survive?. Journal of Nuclear Cardiology 17:2, 177-187
CrossRef282
Loren F. Hiratzka, George L. Bakris, Joshua A. Beckman, Robert M. Bersin, Vincent F. Carr, Donald E. Casey, Kim A. Eagle, Luke K. Hermann, Eric M. Isselbacher, Ella A. Kazerooni, Nicholas T. Kouchoukos, Bruce W. Lytle, Dianna M. Milewicz, David L. Reich, Souvik Sen, Julie A. Shinn, Lars G. Svensson, David M. Williams. (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary. Journal of the American College of Cardiology 55:14, 1509-1544
CrossRef283
Takahiro Uchida, Jeffrey Popma, Gregg W. Stone, Stephen G. Ellis, Mark A. Turco, John A. Ormiston, Toshiya Muramatsu, Masato Nakamura, Shinsuke Nanto, Hiroyoshi Yokoi, Donald S. Baim. (2010) The Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting Stents. JACC: Cardiovascular Interventions 3:4, 403-411
CrossRef284
Michel R Hoenig, Constantine N Aroney, Ian A Scott, Michel R Hoenig. 2010. Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. .
CrossRef285
J. Doostzadeh, S. Bezenek, W.-F. Cheong, P. Sood, L. Schwartz, K. Sudhir. 2010. Clinical Trials in Interventional Cardiology: Focus on XIENCE V Drug-Eluting Stent. .
CrossRef286
Silvana Cicala, Giovanni de Simone, Eva Gerdts, Björn Dahlöf, Lars H Lindholm, Sverre E Kjeldsen, Richard B Devereux. (2010) Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study. Journal of Hypertension1
CrossRef287
Megha Agarwal, Puja K. Mehta, C. Noel Bairey Merz. (2010) Nonacute Coronary Syndrome Anginal Chest Pain. Medical Clinics of North America 94:2, 201-216
CrossRef288
Doron Aronson, Elazer R. Edelman. (2010) Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting. Reviews in Endocrine and Metabolic Disorders 11:1, 75-86
CrossRef289
Scot Garg, Patrick Serruys. (2010) Benefits of and safety concerns associated with drug-eluting coronary stents. Expert Review of Cardiovascular Therapy 8:3, 449-470
CrossRef290
M. L. Simoons, S. Windecker. (2010) Chronic stable coronary artery disease: drugs vs. revascularization. European Heart Journal 31:5, 530-541
CrossRef291
Ronald P. Karlsberg, Matthew J. Budoff, Louise E. J. Thomson, John D. Friedman, Daniel S. Berman. (2010) Reduction in downstream test utilization following introduction of coronary computed tomography in a cardiology practice. The International Journal of Cardiovascular Imaging 26:3, 359-366
CrossRef292
P. Jau, T. Jacob, G. Lecorff, J.-L. Bouvier, P. Novella, V. Bechet, V. Pelet. (2010) Place de la scintigraphie myocardique dans l’angor stable. Médecine Nucléaire 34:3, 178-183
CrossRef293
Thomas H. Marwick. (2010) Echocardiography in the Era of Multimodality Imaging. Heart, Lung and Circulation 19:3, 175-184
CrossRef294
Thorsten Reffelmann, Robert A Kloner. (2010) Ranolazine: an anti-anginal drug with further therapeutic potential. Expert Review of Cardiovascular Therapy 8:3, 319-329
CrossRef295
David Rott. (2010) Prophylactic Coronary Angiography Improves Outcome After Major Vascular Surgery. Journal of the American College of Cardiology 55:13, 1396
CrossRef296
Rosana Gambogi, Marcela Baldizzoni, Henry Albornoz, Carlos Ketzoian, Mariana Cabrera, Gustavo Saona, Abayubá Perna. (2010) Prevención secundaria en pacientes revascularizados coronarios en Uruguay: descripción de un programa, evaluación del control de los factores de riesgo y efecto en la mortalidad. Clínica e Investigación en Arteriosclerosis 22:2, 59-69
CrossRef297
Matthias G. Friedrich. (2010) Current status of cardiovascular magnetic resonance imaging in the assessment of coronary vasculature. Canadian Journal of Cardiology 26, 51A-55A
CrossRef298
Neal B. Patel, Gary J. Balady. (2010) Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus. Reviews in Endocrine and Metabolic Disorders 11:1, 11-20
CrossRef299
Konstantinos Toutouzas, Andreas Synetos, Antonis Karanasos, Maria Drakopoulou, Eleutherios Tsiamis, Stamatios Lerakis, Christodoulos Stefanadis. (2010) Percutaneous Coronary Intervention in Chronic Stable Angina. The American Journal of the Medical Sciences1
CrossRef300
Patrick T. O'Gara. (2010) The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial. Journal of the American College of Cardiology 55:13, 1359-1361
CrossRef301
Austin Leach, Michael Chester. 2010. Chest Pain Syndromes. , 292-307.
CrossRef302
Joachim Seydel, Kathrin-Maria Roy, Langenfeld. (2010) Glossar zu Begriffen der Pharmazeutik. Angewandte Chemie 122:7, 1351-1366
CrossRef303
G. Illuminati, J.-B. Ricco, C. Greco, E. Mangieri, F. Calio', G. Ceccanei, M.A. Pacilè, M. Schiariti, G. Tanzilli, F. Barillà, V. Paravati, G. Mazzesi, F. Miraldi, L. Tritapepe. (2010) Systematic Preoperative Coronary Angiography and Stenting Improves Postoperative Results of Carotid Endarterectomy in Patients with Asymptomatic Coronary Artery Disease: A Randomised Controlled Trial. European Journal of Vascular and Endovascular Surgery 39:2, 139-145
CrossRef304
Michael Lindstaedt, Yasemin Halilcavusogullari, Aydan Yazar, Tim Holland-Letz, Waldemar Bojara, Andreas Mügge, Alfried Germing. (2010) Clinical Outcome Following Conservative vs Revascularization Therapy in Patients With Stable Coronary Artery Disease and Borderline Fractional Flow Reserve Measurements. Clinical Cardiology 33:2, 77-83
CrossRef305
Anthony A. Hilliard, Aaron M. From, Ryan J. Lennon, Mandeep Singh, Amir Lerman, Bernard J. Gersh, David R. Holmes, Charanjit S. Rihal, Abhiram Prasad. (2010) Percutaneous Revascularization for Stable Coronary Artery Disease. JACC: Cardiovascular Interventions 3:2, 172-179
CrossRef306
Rahul Sakhuja, Laura Mauri. (2010) Controversies in the Use of Drug-Eluting Stents for Acute Myocardial Infarction: A Critical Appraisal of the Data. Annual Review of Medicine 61:1, 215-231
CrossRef307
Spencer B. King, John Jeffrey Marshall, Pradyumna E. Tummala. (2010) Revascularization for Coronary Artery Disease: Stents Versus Bypass Surgery. Annual Review of Medicine 61:1, 199-213
CrossRef308
Roberta Rossini, Giuseppe Musumeci, Alessandro Aprile, Orazio Valsecchi. (2010) Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents. Expert Review of Pharmacoeconomics & Outcomes Research 10:1, 49-61
CrossRef309
Matthias E Pfisterer, Michael J Zellweger, Bernard J Gersh. (2010) Management of stable coronary artery disease. The Lancet 375:9716, 763-772
CrossRef310
Peter C. Austin, Andrea Manca, Merrick Zwarenstein, David N. Juurlink, Matthew B. Stanbrook. (2010) A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. Journal of Clinical Epidemiology 63:2, 142-153
CrossRef311
Brian J. Page, Dmitriy Kireyev, William E. Boden. (2010) The Role of Revascularization Versus Medical Therapy in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Current Diabetes Reports 10:1, 10-15
CrossRef312
Oliver Gaemperli, Philipp A. Kaufmann. (2010) Multimodality cardiac imaging. Journal of Nuclear Cardiology 17:1, 4-7
CrossRef313
Chiara Lazzeri, Serafina Valente, Marco Chiostri, Claudio Picariello, Gian Franco Gensini. (2010) Acid–base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis. Internal and Emergency Medicine 5:1, 61-66
CrossRef314
É. Puymirat, D. Blanchard. (2010) Angioplastie coronaire : indications, limites et résultats en dehors des syndromes coronaires aigus en 2009. Annales de Cardiologie et d'Angéiologie 59:1, 25-30
CrossRef315
Tadayuki Uetani, Tetsuya Amano, Ayako Kunimura, Soichiro Kumagai, Hirohiko Ando, Kiminobu Yokoi, Tomohiro Yoshida, Bunichi Kato, Masataka Kato, Nobuyuki Marui, Michio Nanki, Tatsuaki Matsubara, Hideki Ishii, Hideo Izawa, Toyoaki Murohara. (2010) The Association Between Plaque Characterization by CT Angiography and Post-Procedural Myocardial Infarction in Patients With Elective Stent Implantation. JACC: Cardiovascular Imaging 3:1, 19-28
CrossRef316
Masato Nakamura, Hiroyoshi Yokoi, Yuji Hamazaki, Masato Watarai, Mikihiro Kijima, Kazuaki Mitsudo, The Cypher J-PMS Investigators. (2010) Impact of Insulin-Treated Diabetes and Hemodialysis on Long-Term Clinical Outcomes Following Sirolimus-Eluting Stent Deployment. Circulation Journal 74:12, 2592-2597
CrossRef317
Takuroh Imamura. (2010) Should β-Blockers Be Prescribed More Frequently to Japanese Patients With Coronary Artery Disease?. Circulation Journal 74:5, 848-849
CrossRef318
Shinro Matsuo, Kenichi Nakajima, Yoshimitsu Yamasaki, Atsunori Kashiwagi, Tsunehiko Nishimura. (2010) Prognostic Value of Normal Stress Myocardial Perfusion Imaging and Ventricular Function in Japanese Asymptomatic Patients With Type 2 Diabetes. Circulation Journal 74:9, 1916-1921
CrossRef319
Carolyn M. Clancy. (2010) The Promise and Future of Comparative Effectiveness Research. Journal of Nursing Care Quality 25:1, 1-4
CrossRef320
Zoltán Vokó, Nicolas Danchin, Sophie de Brouwer, Bridget-Anne Kirwan, Philip A. Poole-Wilson, Jacobus Lubsen. (2010) Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: The ACTION experience. International Journal of Cardiology 138:1, 56-62
CrossRef321
Chiara Lazzeri, Marco Chiostri, Andrea Sori, Serafina Valente, Gian Franco Gensini. (2010) Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. Journal of Cardiovascular Medicine 11:1, 7-13
CrossRef322
Morton J. Kern, Habib Samady. (2010) Current Concepts of Integrated Coronary Physiology in the Catheterization Laboratory. Journal of the American College of Cardiology 55:3, 173-185
CrossRef323
Shepard D. Weiner, LeRoy E. Rabbani. (2010) Secondary prevention strategies for coronary heart disease. Journal of Thrombosis and Thrombolysis 29:1, 8-24
CrossRef324
Kazuhiro SASE. (2010) Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 41:4, 133-139
CrossRef325
Susumu Manabe, Shuichiro Takanashi. (2010) Surgical Revascularization for the Elderly Patients. Japanese Journal of Cardiovascular Surgery 39:5, 235-241
CrossRef326
Ankur Sethi, Amol Bahekar, Rohit Bhuriya. (2010) Is Appropriate Use Criteria for Cardiac Radionuclide Imaging in Asymptomatic Diabetic Patients Evidence Based?. Journal of the American College of Cardiology 55:3, 260
CrossRef327
Robert C. Hendel, Michael J. Wolk. (2010) Reply. Journal of the American College of Cardiology 55:3, 260-261
CrossRef328
Tomohiro Sakamoto, Hisao Ogawa. (2010) "Just Make It Lower" Is an Alternative Strategy of Lipid-Lowering Therapy With Statins in Japanese Patients. Circulation Journal 74:8, 1731-1741
CrossRef329
Paul Wexberg, Franz Weidinger. (2010) Revaskularisation der koronaren Herzerkrankung bei Diabetes mellitus. Wiener Medizinische Wochenschrift 160:1-2, 40-43
CrossRef330
Alessandro Desideri. (2010) Invasive or Non-Iinvasive? That Is (Still) the Question. Circulation Journal 74:5, 1028
CrossRef331
Mariusz Kruk, Christopher E. Buller, James Enlou Tcheng, Vladimir Dzavík, Venugopal Menon, G.B. John Mancini, Sandra A. Forman, Peter Kurray, Benita Busz-Papiez, Gervasio A. Lamas, Judith S. Hochman. (2010) Impact of Left Ventricular Ejection Fraction on Clinical Outcomes Over Five Years After Infarct-Related Coronary Artery Recanalization (from the Occluded Artery Trial [OAT]). The American Journal of Cardiology 105:1, 10-16
CrossRef332
Masaru Nishimi, Tadashi Tashiro. (2010) Off-Pump Coronary Artery Bypass vs Percutaneous Coronary Intervention. Circulation Journal 74:12, 2750-2757
CrossRef333
Jiro Aoki. (2010) Application of Drug Eluting Stents to Clinical Practice in Japan. Circulation Journal 74:8, 1532-1533
CrossRef334
Benjamin Williams, Madhav Menon, Daniel Satran, Daniel Hayward, James S. Hodges, M. Nicholas Burke, Randall K. Johnson, Anil K. Poulose, Jay H. Traverse, Timothy D. Henry. (2010) Patients with coronary artery disease not amenable to traditional revascularization: Prevalence and 3-year mortality. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef335
Atsushi Tanaka, Guillermo J. Tearney, Brett E. Bouma. (2010) Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography. Journal of Biomedical Optics 15:1, 011104
CrossRef336
Krista L. Lentine, Frank P. Hurst, Rahul M. Jindal, Todd C. Villines, Jeffrey S. Kunz, Christina M. Yuan, Paul J. Hauptman, Kevin C. Abbott. (2010) Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and Controversies. American Journal of Kidney Diseases 55:1, 152-167
CrossRef337
Lauro Cortigiani, Fausto Rigo, Sonia Gherardi, Francesco Bovenzi, Eugenio Picano, Rosa Sicari. (2010) Implication of the Continuous Prognostic Spectrum of Doppler Echocardiographic Derived Coronary Flow Reserve on Left Anterior Descending Artery. The American Journal of Cardiology 105:2, 158-162
CrossRef338
Gianluca Campo, Marco Valgimigli, Alice Frangione, Serena Luccarelli, Elisa Cangiano, Caterina Cavazza, Luca Fileti, Roberto Ferrari. (2010) Evaluation of Platelet Inhibition by Tirofiban in Patients Stratified According to Aspirin and Clopidogrel Responsiveness. Journal of the American College of Cardiology 55:3, 255-256
CrossRef339
Takahide Kohro, Dobun Hayashi, Tsutomu Yamazaki, Ryozo Nagai, The JCAD Investigators. (2010) Beta-Blocker Prescription Among Japanese Cardiologists and Its Effect on Various Outcomes. Circulation Journal 74:5, 962-969
CrossRef340
Alberto Cordero, Lorenzo Fácila, Enrique Galve, Pilar Mazón. (2010) Novedades en hipertensión arterial y diabetes mellitus. Revista Española de Cardiología 63, 101-115
CrossRef341
Valentín Fuster. (2010) De la enfermedad multivaso compleja a la salud cardiovascular. Revista Española de Cardiología 63, 3-11
CrossRef342
Takayuki Ohno, Osamu Kinoshita, Hideo Fujita, Satoshi Kato, Akira Hirose, Takashi Sigeeda, Kazuyoshi Otomo, Jiro Ando, Takashi Kadowaki, Makoto Araie, Ryozo Nagai, Shinichi Takamoto. (2010) Detecting occult coronary artery disease followed by early coronary artery bypass surgery in patients with diabetic retinopathy: Report from a diabetic retinocoronary clinic. The Journal of Thoracic and Cardiovascular Surgery 139:1, 92-97
CrossRef343
Yoshihiro Morino. (2010) Modifying the Drug Elution Profile for Neointimal Control. Circulation Journal 74:10, 2054-2055
CrossRef344
K. A.A. Fox, J.-P. Despres, A.-J. Richard, S. Brette, J. E. Deanfield, . (2009) Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91 246 ambulant patients in 27 European Countries. European Heart Journal 30:24, 3055-3063
CrossRef345
Michael R. Freeman. (2009) Growing evidence that radionuclide imaging identifies management strategies that improve outcome. Journal of Nuclear Cardiology 16:6, 844-845
CrossRef346
Toshiko Uchida, Stephen D. Persell, David W. Baker. (2009) Update in General Internal Medicine. Journal of General Internal Medicine 24:12, 1327-1332
CrossRef347
Frans J. Th. Wackers, Lawrence H. Young. (2009) Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study. Journal of Nuclear Cardiology 16:6, 855-859
CrossRef348
Joseph A. Ladapo, Farouc A. Jaffer, Udo Hoffmann, Carey C. Thomson, Fabian Bamberg, William Dec, David M. Cutler, Milton C. Weinstein, G. Scott Gazelle. (2009) Clinical Outcomes and Cost-Effectiveness of Coronary Computed Tomography Angiography in the Evaluation of Patients With Chest Pain. Journal of the American College of Cardiology 54:25, 2409-2422
CrossRef349
O. Gaemperli, L. Husmann, T. Schepis, P. Koepfli, I. Valenta, W. Jenni, H. Alkadhi, T. F. Luscher, P. A. Kaufmann. (2009) Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a potential gatekeeper for coronary revascularization?. European Heart Journal 30:23, 2921-2929
CrossRef350
Enrique Asín Cardiel, Nekane Murga. (2009) Current Analysis of the Results of the COURAGE Trial. American Journal Cardiovascular Drugs 9:Supplement 1, 19-21
CrossRef351
Miklós D. Kertai, János Gál. (2009) Preoperative coronary revascularization for the reduction of perioperative ischemic complications in patients undergoing major vascular surgery. Interventional Medicine and Applied Science 1:1, 12-19
CrossRef352
M. Bashar Al-Housni, Fiona Hutchings, Miles Dalby, Michael Dubowitz, Richard Grocott-Mason, Charles D. J. Ilsley, Mark Mason, Andrew G. Mitchell, Andrew D. Kelion. (2009) Does myocardial perfusion scintigraphy predict improvement in symptoms and exercise capacity following successful elective percutaneous coronary intervention?. Journal of Nuclear Cardiology 16:6, 869-877
CrossRef353
Matthew A. Cavender, Karen P. Alexander, Samuel Broderick, Linda K. Shaw, Charles B. McCants, Judith Kempf, E. Magnus Ohman. (2009) Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease. American Heart Journal 158:6, 933-940
CrossRef354
Konstantinos C Koskinas, Yiannis S Chatzizisis, Aaron B Baker, Elazer R Edelman, Peter H Stone, Charles L Feldman. (2009) The role of low endothelial shear stress in the conversion of atherosclerotic lesions from stable to unstable plaque. Current Opinion in Cardiology 24:6, 580-590
CrossRef355
Anwar Tandar, William E Boden. (2009) Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy. Current Opinion in Cardiology 24:6, 591-595
CrossRef356
Miles Dalby, Rajesh Kharbanda, Gopal Ghimire, Jon Spiro, Phil Moore, Michael Roughton, Rebecca Lane, Mohammad Al-Obaidi, Molly Teoh, Elizabeth Hutchison, Mark Whitbread, David Fountain, Richard Grocott-Mason, Andrew Mitchell, Mark Mason, Charles Ilsley. (2009) Achieving routine sub 30 minute door-to-balloon times in a high volume 24/7 primary angioplasty center with autonomous ambulance diagnosis and immediate catheter laboratory access. American Heart Journal 158:5, 829-835
CrossRef357
(2009) Therapies for Type 2 Diabetes and Coronary Artery Disease. New England Journal of Medicine 361:14, 1407-1410
Full Text358
Alessia Gimelli, Paolo Marzullo, Daniele Rovai. (2009) Physiologic risk assessment in stable ischemic heart disease: still superior to the anatomic angiographic approach. Journal of Nuclear Cardiology 16:5, 697-700
CrossRef359
Michael Stoner. (2009) Invited commentary. Journal of Vascular Surgery 50:4, 945
CrossRef360
William W. Ashley, Jr, Gregory J. Zipfel, Christopher J. Moran, Jie Zheng, Colin P. Derdeyn. (2009) Moyamoya Phenomenon Secondary to Intracranial Atherosclerotic Disease: Diagnosis by 3T Magnetic Resonance Imaging. Journal of Neuroimaging 19:4, 381-384
CrossRef361
E. E. Buschmann, W. Utz, N. Pagonas, J. Schulz-Menger, A. Busjahn, J. Monti, W. Maerz, F. le Noble, L. Thierfelder, R. Dietz, V. Klauss, M. Gross, I.R. Buschmann, . (2009) Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial). European Journal of Clinical Investigation 39:10, 866-875
CrossRef362
David J. Maron, John A. Spertus, G.B. John Mancini, Pamela M. Hartigan, Steven P. Sedlis, Eric R. Bates, William J. Kostuk, Marcin Dada, Daniel S. Berman, Leslee J. Shaw, Bernard R. Chaitman, Koon K. Teo, Robert A. O'Rourke, William S. Weintraub, William E. Boden. (2009) Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial. The American Journal of Cardiology 104:8, 1055-1062
CrossRef363
Jeffrey W Moses. (2009) On the misinterpretation of clinical trials. Interventional Cardiology 1:1, 3-5
CrossRef364
Leslee J. Shaw, Raffaelle Bugiardini, C. Noel Bairey Merz. (2009) Women and Ischemic Heart Disease. Journal of the American College of Cardiology 54:17, 1561-1575
CrossRef365
Eue-Keun Choi, Eun Ju Chun, Sang-Il Choi, Sung-A. Chang, Sung-Hee Choi, Soo Lim, Juan J. Rivera, Khurram Nasir, Roger S. Blumenthal, Hak-Chul Jang, Hyuk-Jae Chang. (2009) Assessment of Subclinical Coronary Atherosclerosis in Asymptomatic Patients With Type 2 Diabetes Mellitus With Single Photon Emission Computed Tomography and Coronary Computed Tomography Angiography. The American Journal of Cardiology 104:7, 890-896
CrossRef366
Chiara Lazzeri, Andrea Sori, Marco Chiostri, Gian Franco Gensini, Serafina Valente. (2009) Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. European Journal of Anaesthesiology 26:10, 856-862
CrossRef367
Roberta Ara, Rachid Rafia, Sue E Ward, Anthony S Wierzbicki, Tim M Reynolds, Angie Rees, Abdullah Pandor. (2009) Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective. Expert Review of Pharmacoeconomics & Outcomes Research 9:5, 423-433
CrossRef368
Aiden Abidov, Michael J. Gallagher, Kavitha M. Chinnaiyan, Laxmi S. Mehta, James H. Wegner, Gilbert L. Raff. (2009) Clinical effectiveness of coronary computed tomographic angiography in the triage of patients to cardiac catheterization and revascularization after inconclusive stress testing: results of a 2-year prospective trial. Journal of Nuclear Cardiology 16:5, 701-713
CrossRef369
Oliver Bruder, Steffen Schneider, Detlef Nothnagel, Thorsten Dill, Vinzenz Hombach, Jeanette Schulz-Menger, Eike Nagel, Massimo Lombardi, Albert C. van Rossum, Anja Wagner, Juerg Schwitter, Jochen Senges, Georg V. Sabin, Udo Sechtem, Heiko Mahrholdt. (2009) EuroCMR (European Cardiovascular Magnetic Resonance) Registry. Journal of the American College of Cardiology 54:15, 1457-1466
CrossRef370
Friedrich D. Knollmann, Annika Wieltsch, Simone Peters, Anika Mahlke, Susanne Niederberger, Tereza Kertesz. (2009) Flat Panel Volume Computed Tomography of the Coronary Arteries. Academic Radiology 16:10, 1251-1262
CrossRef371
Nikolaos Alexopoulos, Paolo Raggi. (2009) Calcification in atherosclerosis. Nature Reviews Cardiology 6:11, 681-688
CrossRef372
W. Wijns, P. Kolh. (2009) Appropriate myocardial revascularization: a joint viewpoint from an interventional cardiologist and a cardiac surgeon. European Heart Journal 30:18, 2182-2185
CrossRef373
William R. Lewis. (2009) COUNTERPOINT: Mechanical Treatment of Atherosclerosis Is Not a Cure. Preventive Cardiology 12:4, 171-172
CrossRef374
Christian Albus, Peter Theissen, Martin Hellmich, Reinhard Griebenow, Beate Wilhelm, Demet Aslim, Harald Schicha, Karl Köhle. (2009) Long-Term Effects of a Multimodal Behavioral Intervention on Myocardial Perfusion—a Randomized Controlled Trial. International Journal of Behavioral Medicine 16:3, 219-226
CrossRef375
Myrvin H. Ellestad. (2009) POINT: A Prescription to Decrease Left Ventricular Function. Preventive Cardiology 12:4, 169-170
CrossRef376
Matthew J. Budoff, Robert Karwasky, Naser Ahmadi, Cyrus Nasserian, Frank Pratt, Jamey Stephens, William W. Chang, Ferdinand R. Flores, John A. Rizzo, Candace L. Gunnarsson, Charles R. McKay. (2009) Cost-effectiveness of multidetector computed tomography compared with myocardial perfusion imaging as gatekeeper to invasive coronary angiography in asymptomatic firefighters with positive treadmill tests. Journal of Cardiovascular Computed Tomography 3:5, 323-330
CrossRef377
Eiji Toyota, Yoshinori Miyamoto, Koichiro Imai, Yoji Neishi, Takahiro Kawamoto, Hiroyuki Okura, Kiyoshi Yoshida. (2009) DEVELOPMENT OF CARDIAC DYSFUNCTION INDUCED BY REPETITIVE TRANSIENT MYOCARDIAL ISCHAEMIA IS INHIBITED BY EDARAVONE IN CONSCIOUS RATS. Clinical and Experimental Pharmacology and Physiology 36:9, e20-e25
CrossRef378
Koon K. Teo, Steven P. Sedlis, William E. Boden, Robert A. O'Rourke, David J. Maron, Pamela M. Hartigan, Marcin Dada, Vipul Gupta, John A. Spertus, William J. Kostuk, Daniel S. Berman, Leslee J. Shaw, Bernard R. Chaitman, G.B. John Mancini, William S. Weintraub. (2009) Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease. Journal of the American College of Cardiology 54:14, 1303-1308
CrossRef379
Roger S. Blumenthal, Chao-Wei Hwang, Khurram Nasir. (2009) Selective Use of Coronary Artery Calcium Screening. Journal of the American College of Cardiology 54:14, 1268-1270
CrossRef380
Grace A Lin, Rita F Redberg. (2009) Use of stress testing prior to percutaneous coronary intervention in patients with stable coronary artery disease. Expert Review of Cardiovascular Therapy 7:9, 1061-1066
CrossRef381
James B. Froehlich, Lee A. Fleisher. (2009) Noncardiac Surgery in the Patient with Heart Disease. Medical Clinics of North America 93:5, 995-1016
CrossRef382
Jaap N. Hamburger, Simon J. Walsh, Rohit Khurana, Lillian Ding, Min Gao, Karin H. Humphries, Ronald Carere, Anthony Y. Fung, Richard R. Mildenberger, Gerald J. Simkus, John G. Webb, Christopher E. Buller. (2009) Percutaneous coronary intervention and 30-day mortality: The British Columbia PCI risk score. Catheterization and Cardiovascular Interventions 74:3, 377-385
CrossRef383
Carlo Di Mario. (2009) Informed consent in interventional cardiology. EuroIntervention 5:4, 415-416
CrossRef384
Alberto Cordero, Vicente Bertomeu-Martínez, Pilar Mazón, Juan Quiles, Joaquín Aznar, Héctor Bueno. (2009) Differences in Medical Treatment of Chronic Coronary Heart Disease Patients According to Medical Specialities. Cardiovascular Therapeutics 27:3, 173-180
CrossRef385
Walter J. Gomes. (2009) Hybrid Coronary Artery Revascularization: An Evidence-Based Analysis. The Annals of Thoracic Surgery 88:3, 1047
CrossRef386
Louai Razzouk, Paul Muntner, Sameer Bansilal, Annapoorna S. Kini, Ashish Aneja, Joshua Mozes, Oana Ivan, Madhavi Jakkula, Samin Sharma, Michael E. Farkouh. (2009) C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. American Heart Journal 158:2, 277-283
CrossRef387
Brett M. Wertman, Victor Y. Cheng, Saibal Kar, Heidi Gransar, Ryan A. Berg, Hursh Naik, Rajendra Makkar, John D. Friedman, Jay N. Schapira, Daniel S. Berman. (2009) Characterization of Complex Coronary Artery Stenosis Morphology by Coronary Computed Tomographic Angiography. JACC: Cardiovascular Imaging 2:8, 950-958
CrossRef388
Brett D. Atwater, James Oujiri, Matthew R. Wolff. (2009) The Immediate Impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial on the Management of Stable Angina. Clinical Cardiology 32:8, E1-E3
CrossRef389
Alfred A. Bove. (2009) President's Page: Looking Beyond the Politics of Health Care Reform. Journal of the American College of Cardiology 54:6, 570-572
CrossRef390
Jacobijne J. Wiersma, Hein J. Verberne, Wik L. Holt, Ineke M. Radder, Lea M. Dijksman, Berthe L. F. Eck-Smit, Mieke D. Trip, Jan G. P. Tijssen, Jan J. Piek. (2009) Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris. Journal of Nuclear Cardiology 16:4, 524-532
CrossRef391
George A. Beller. (2009) Implications of randomized studies of medical therapy vs revascularization for reducing rising costs of health care. Journal of Nuclear Cardiology 16:4, 483-485
CrossRef392
Mohammad Movahed, Radhakrishnan Ramaraj, M. Jamal, Mehrtash Hashemzadeh. (2009) Nationwide trends in the utilisation of percutaneous coronary intervention (PCI) in the United States of America based on gender and ethnicities. EuroIntervention 5:3, 343-348
CrossRef393
Robert J. Gropler. (2009) Making the case for physiologically guided percutaneous coronary interventions in patients with chronic coronary artery disease. Current Cardiovascular Imaging Reports 2:4, 253-254
CrossRef394
Stephan Gielen, Marcus Sandri, Gerhard Schuler, Daniel Teupser. (2009) Risk factor management: antiatherogenic therapies. European Journal of Cardiovascular Prevention & Rehabilitation 16:Supplement 1, S29-S36
CrossRef395
K. Lance Gould. (2009) Does Coronary Flow Trump Coronary Anatomy?. JACC: Cardiovascular Imaging 2:8, 1009-1023
CrossRef396
David R Holmes, Vivek Y Reddy, Zoltan G Turi, Shephal K Doshi, Horst Sievert, Maurice Buchbinder, Christopher M Mullin, Peter Sick. (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. The Lancet 374:9689, 534-542
CrossRef397
D. G. Jones, A. M. Taylor, S. A. Enkiri, P. Lobo, K. L. Brayman, E. C. Keeley, L. C. Lipson, L. W. Gimple, M. Ragosta. (2009) Extent and Severity of Coronary Disease and Mortality in Patients with End-Stage Renal Failure Evaluated for Renal Transplantation. American Journal of Transplantation 9:8, 1846-1852
CrossRef398
J. H. O'Keefe, M. D. Carter, C. J. Lavie. (2009) Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach. Mayo Clinic Proceedings 84:8, 741-757
CrossRef399
Abhiram Prasad, Bernard J. Gersh, Michel E. Bertrand, A. Michael Lincoff, Jeffrey W. Moses, E. Magnus Ohman, Harvey D. White, Stuart J. Pocock, Brent T. McLaurin, David A. Cox, Alexandra J. Lansky, Roxana Mehran, Gregg W. Stone. (2009) Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology 54:5, 477-486
CrossRef400
Patrick Serruys, Scot Garg. (2009) Intervencionismo coronario percutáneo para todos los pacientes con enfermedad coronaria compleja: enfermedad de tres vasos o del tronco izquierdo. ¿Verdadero? ¿Falso? ¿No se sabe?. Revista Española de Cardiología 62:7, 719-725
CrossRef401
C. Richard Conti. (2009) Some Clinical Trials Get No Respect. Clinical Cardiology 32:7, 356-357
CrossRef402
N. Mottard, J.-S. David, N. Mewton, M. Abdellaoui, A. Cheron, C. Macabeo, E. Bonnefoy, V. Piriou. (2009) Infarctus du myocarde peropératoire, quelle prise en charge à la phase aiguë ?. Annales Françaises d’Anesthésie et de Réanimation 28:7-8, 692-696
CrossRef403
Somjot S. Brar, Gregg W. Stone. (2009) Advances in percutaneous coronary intervention. Current Cardiology Reports 11:4, 245-251
CrossRef404
Otavio R. Coelho-Filho, Leelakrishna Nallamshetty, Raymond Y. Kwong. (2009) Risk Stratification for Therapeutic Management and Prognosis. Heart Failure Clinics 5:3, 437-455
CrossRef405
Anis Rassi. (2009) Prognostic Utility of Coronary Computed Tomography Angiography. JACC: Cardiovascular Imaging 2:7, 914
CrossRef406
Gerald S. Werner, Anselm K. Gitt, Uwe Zeymer, Claus Juenger, Frank Towae, Harm Wienbergen, Jochen Senges. (2009) Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice. Clinical Research in Cardiology 98:7, 435-441
CrossRef407
Dean Ornish. (2009) Intensive lifestyle changes and health reform. The Lancet Oncology 10:7, 638-639
CrossRef408
William E. Boden, Robert A. O'Rourke, Koon K. Teo, David J. Maron, Pamela M. Hartigan, Steven P. Sedlis, Marcin Dada, Mohammed Labedi, John A. Spertus, William J. Kostuk, Daniel S. Berman, Leslee J. Shaw, Bernard R. Chaitman, G.B. John Mancini, William S. Weintraub. (2009) Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial). The American Journal of Cardiology 104:1, 1-4
CrossRef409
Vicente Bertomeu, Alberto Cordero, Juan Quiles, Pilar Mazón, Joaquín Aznar, Héctor Bueno. (2009) Control de los factores de riesgo y tratamiento de los pacientes con cardiopatía isquémica: registro TRECE. Revista Española de Cardiología 62:7, 807-811
CrossRef410
Boden, William E., Taggart, David P., . (2009) Diabetes with Coronary Disease — A Moving Target amid Evolving Therapies?. New England Journal of Medicine 360:24, 2570-2572
Full Text411
The BARI 2D Study Group. (2009) A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. New England Journal of Medicine 360:24, 2503-2515
Full Text412
Pedro Lemos, Carlos Campos, João Falcão, Expedito Ribeiro, Marco Perin, Luiz Kajita, Antonio Filho, Marcus da Gama, Pedro Horta, Gilberto Marchiori, Andre Spadaro, Eulógio Martinez. (2009) Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention. EuroIntervention 5:2, 239-243
CrossRef413
Philipp A. Kaufmann. (2009) Cardiac hybrid imaging: state-of-the-art. Annals of Nuclear Medicine 23:4, 325-331
CrossRef414
Martin B. Leon, Dominic J. Allocco, Keith D. Dawkins, Donald S. Baim. (2009) Late Clinical Events After Drug-Eluting Stents. JACC: Cardiovascular Interventions 2:6, 504-512
CrossRef415
John J. Mahmarian. (2009) Myocardial perfusion imaging to evaluate the efficacy of medical therapy in patients with coronary artery disease. Current Cardiovascular Imaging Reports 2:3, 183-196
CrossRef416
Carlo Di Mario. (2009) Ars Longa, Vita Brevis
Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.. JACC: Cardiovascular Interventions 2:6, 487-488
CrossRef417
René M. Botnar. (2009) Coronary Plaque Characterization by T1-Weighted Cardiac Magnetic Resonance. JACC: Cardiovascular Imaging 2:6, 729-730
CrossRef418
Merril L. Knudtson, Colleen M. Norris, P. Diane Galbraith, Jaro Hubacek, William A. Ghali. (2009) Explicit risk in acute coronary syndrome management. Canadian Journal of Cardiology 25, 29A-36A
CrossRef419
Gabriel S. Aldea, Nahush A. Mokadam, Rayland Melford, Douglas Stewart, Charles Maynard, Mark Reisman, Richard Goss. (2009) Changing Volumes, Risk Profiles, and Outcomes of Coronary Artery Bypass Grafting and Percutaneous Coronary Interventions. The Annals of Thoracic Surgery 87:6, 1828-1838
CrossRef420
Giovanna Sarno, Isabel Decraemer, Piet K. Vanhoenacker, Bernard De Bruyne, Michalis Hamilos, Thomas Cuisset, Eric Wyffels, Jozef Bartunek, Guy R. Heyndrickx, William Wijns. (2009) On the Inappropriateness of Noninvasive Multidetector Computed Tomography Coronary Angiography to Trigger Coronary Revascularization. JACC: Cardiovascular Interventions 2:6, 550-557
CrossRef421
Paul Kurlansky. (2009) Invited Commentary. The Annals of Thoracic Surgery 87:6, 1838
CrossRef422
Robert A. Vogel. (2009) Drug-Eluting Stents: Safe But Not Sufficient
CrossRef423
Henri Roukoz, Anthony A. Bavry, Michael L. Sarkees, Girish R. Mood, Dharam J. Kumbhani, Mark G. Rabbat, Deepak L. Bhatt. (2009) Comprehensive Meta-Analysis on Drug-Eluting Stents versus Bare-Metal Stents during Extended Follow-up. The American Journal of Medicine 122:6, 581.e1-581.e10
CrossRef424
Marco V. Wainstein, Jorge P. Ribeiro. (2009) Mechanical plaque sealing in patients with acute coronary syndromes. International Journal of Cardiology 135:1, 105-106
CrossRef425
B. Pitt. (2009) Angiotensin-converting enzyme inhibitors in patients with vascular disease. European Heart Journal 30:11, 1307-1309
CrossRef426
MOHAMMAD REZA MOVAHED, RADHAKRISHNAN RAMARAJ, M. MAZEN JAMAL, MEHRTASH HASHEMZADEH. (2009) Nationwide Trends in the Utilization of Multivessel Percutaneous Coronary Intervention (MVPCI) in the United States across Different Gender and Ethnicities. Journal of Interventional Cardiology 22:3, 247-251
CrossRef427
(2009) Fractional Flow Reserve for Guiding PCI. New England Journal of Medicine 360:19, 2024-2027
Full Text428
L. Bjorck, A. Rosengren, K. Bennett, G. Lappas, S. Capewell. (2009) Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. European Heart Journal 30:9, 1046-1056
CrossRef429
Ranil de Silva, Kim M. Fox. (2009) Angina: Ivabradine for treatment of stable angina pectoris. Nature Reviews Cardiology 6:5, 329-330
CrossRef430
William F Fearon. (2009) Expanding role of fractional flow reserve in the cardiac catheterization laboratory. Expert Review of Cardiovascular Therapy 7:5, 447-449
CrossRef431
Sreekumar Subramanian, Joseph F. Sabik, Penny L. Houghtaling, Edward R. Nowicki, Eugene H. Blackstone, Bruce W. Lytle. (2009) Decision-Making for Patients With Patent Left Internal Thoracic Artery Grafts to Left Anterior Descending. The Annals of Thoracic Surgery 87:5, 1392-1400
CrossRef432
Gian Paolo Fadini, Saula Vigili de Kreutzenberg, Antonio Tiengo, Angelo Avogaro. (2009) Why to screen heart disease in diabetes. Atherosclerosis 204:1, 11-15
CrossRef433
Domenico Scrutinio, Pier Luigi Temporelli, Andrea Passantino, Pantaleo Giannuzzi. (2009) Long-term secondary prevention programs after cardiac rehabilitation for the reduction of future cardiovascular events: focus on regular physical activity. Future Cardiology 5:3, 297-314
CrossRef434
Ramón Arroyo-Espliguero, Pablo Avanzas, Juan Quiles, Juan Carlos Kaski. (2009) Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis 204:1, 239-243
CrossRef435
O. Gaemperli, P. A. Kaufmann. (2009) Kardiale Hybridbildgebung. Clinical Research in Cardiology Supplements 4:S2, 127-134
CrossRef436
Brian Horst, Charanjit S. Rihal, David R. Holmes, John F. Bresnahan, Abhiram Prasad, Gerald Gau, Ryan Lennon, Amir Lerman. (2009) Comparison of Drug-Eluting and Bare-Metal Stents for Stable Coronary Artery Disease. JACC: Cardiovascular Interventions 2:4, 321-328
CrossRef437
Steven E. Nissen. (2009) The Vulnerable Plaque “Hypothesis”. JACC: Cardiovascular Imaging 2:4, 483-485
CrossRef438
James R. Margolis. (2009) The Excel Stent: A Good DES, But Can We Really Stop Clopidogrel After 6 Months?
CrossRef439
Nuno Bettencourt, Eike Nagel. (2009) Detección de isquemia con resonancia magnética cardiaca de estrés con vasodilatadores: ventajas de un enfoque combinado. Revista Española de Cardiología 62:4, 350-353
CrossRef440
Sean R. Wilson, Benjamin M. Scirica, Eugene Braunwald, Sabina A. Murphy, Ewa Karwatowska-Prokopczuk, Jacqueline L. Buros, Bernard R. Chaitman, David A. Morrow. (2009) Efficacy of Ranolazine in Patients With Chronic Angina. Journal of the American College of Cardiology 53:17, 1510-1516
CrossRef441
Olaf Schouten, Jan-Peter van Kuijk, Willem-Jan Flu, Tamara A. Winkel, Gijs M.J.M. Welten, Eric Boersma, Hence J.M. Verhagen, Jeroen J. Bax, Don Poldermans. (2009) Long-Term Outcome of Prophylactic Coronary Revascularization in Cardiac High-Risk Patients Undergoing Major Vascular Surgery (from the Randomized DECREASE-V Pilot Study). The American Journal of Cardiology 103:7, 897-901
CrossRef442
George C.M. Siontis, Athina Tatsioni, Demosthenes G. Katritsis, John P.A. Ioannidis. (2009) Persistent reservations against contradicted percutaneous coronary intervention indications: Citation content analysis. American Heart Journal 157:4, 695-701
CrossRef443
Eike Nagel. (2009) Taking the Last Hurdles: Magnetic Resonance Myocardial Perfusion Imaging. JACC: Cardiovascular Imaging 2:4, 434-436
CrossRef444
David P Taggart. (2009) PCI or CABG in coronary artery disease?. The Lancet 373:9670, 1150-1152
CrossRef445
John K. French, Jennifer A. Shearer. (2009) Are we letting good stories obscure the truth—Can qualitative techniques provide clarification?. American Heart Journal 157:4, 597-598
CrossRef446
Juan Sanchis, Vicent Bodí, Julio Núñez, Luis Mainar, Eduardo Núñez, Pilar Merlos, Eva Rúmiz, Gema Miñana, Xavier Bosch, Angel Llácer. (2009) Efficacy of Coronary Revascularization in Patients With Acute Chest Pain Managed in a Chest Pain Unit. Mayo Clinic Proceedings 84:4, 323-329
CrossRef447
Warren J. Cantor, Sergio B. Baptista, Vankeepuram S. Srinivas, Camille A. Pearte, Venu Menon, Zygmunt Sadowski, John R. Ross, Peter Meciar, Eugenia Nikolsky, Sandra A. Forman, Gervasio A. Lamas, Judith S. Hochman. (2009) Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: Analysis from the occluded artery trial. American Heart Journal 157:4, 666-672
CrossRef448
J. Sanchis, V. Bodi, J. Nunez, L. Mainar, E. Nunez, P. Merlos, E. Rumiz, G. Minana, X. Bosch, A. Llacer. (2009) Efficacy of Coronary Revascularization in Patients With Acute Chest Pain Managed in a Chest Pain Unit. Mayo Clinic Proceedings 84:4, 323-329
CrossRef449
(2009) Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension. New England Journal of Medicine 360:11, 1147-1150
Full Text450
Linda B. Haramati, Jeffrey M. Levsky, Vineet R. Jain, Erik J. Altman, Hugo Spindola-Franco, Shalini Bobra, Sanjay Doddamani, Mark I. Travin. (2009) CT angiography for evaluation of coronary artery disease in inner-city outpatients: an initial prospective comparison with stress myocardial perfusion imaging. The International Journal of Cardiovascular Imaging 25:3, 303-313
CrossRef451
Thomas A Trikalinos, Alawi A Alsheikh-Ali, Athina Tatsioni, Brahmajee K Nallamothu, David M Kent. (2009) Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. The Lancet 373:9667, 911-918
CrossRef452
Debabrata Mukherjee, David J Moliterno. (2009) Effectiveness of PCI for non-acute coronary artery disease. The Lancet 373:9667, 870-872
CrossRef453
Benjamin J.W. Chow, Eric Larose, Sylvie Bilodeau, Mary Lou Ellins, Paul Galiwango, Malek Kass, Tej Sheth, Davinder S. Jassal, Iain D.C. Kirkpatrick, G.B. John Mancini, John Mayo, Arun Abraham, James White. (2009) The ‘what, when, where, who and how?’ of cardiac computed tomography in 2009: Guidelines for the clinician. Canadian Journal of Cardiology 25:3, 135-139
CrossRef454
Sripal Bangalore, Siu-Sun Yao, Farooq A. Chaudhry. (2009) Prediction of Myocardial Infarction Versus Cardiac Death by Stress Echocardiography. Journal of the American Society of Echocardiography 22:3, 261-267
CrossRef455
Sundeep Chaudhry, Ross Arena, Karlman Wasserman, James E. Hansen, Gregory D. Lewis, Jonathan Myers, Nicolas Chronos, William E. Boden. (2009) Exercise-Induced Myocardial Ischemia Detected by Cardiopulmonary Exercise Testing. The American Journal of Cardiology 103:5, 615-619
CrossRef456
Robert M. Califf, Eric D. Peterson. (2009) Public Reporting of Quality Measures. Journal of the American College of Cardiology 53:10, 831-833
CrossRef457
Robert T. Faillace, Raja'a Kaddaha, Mahesh Bikkina, Thil Yogananthan, Rupen Parikh, Pierre Casthley. (2009) The Role of the Out-of-Operating Room Anesthesiologist in the Care of the Cardiac Patient. Anesthesiology Clinics 27:1, 29-46
CrossRef458
J.-C. Tardif, P. Ponikowski, T. Kahan, . (2009) Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. European Heart Journal 30:5, 540-548
CrossRef459
A. Sajadieh. (2009) A new combination therapy in stable angina pectoris. European Heart Journal 30:5, 524-525
CrossRef460
L. Husmann, B. A. Herzog, O. Gaemperli, F. Tatsugami, N. Burkhard, I. Valenta, P. Veit-Haibach, C. A. Wyss, U. Landmesser, P. A. Kaufmann. (2009) Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography/computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering vs. retrospective gating. European Heart Journal 30:5, 600-607
CrossRef461
J. A. Laukkanen, T. H. Makikallio, R. Rauramaa, S. Kurl. (2009) Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study. European Heart Journal 30:5, 558-565
CrossRef462
John G.F. Cleland, Luigi Tavazzi, Jean-Claude Daubert, Ahmed Tageldien, Nick Freemantle. (2009) Cardiac Resynchronization Therapy. Journal of the American College of Cardiology 53:7, 608-611
CrossRef463
Robert A. Vogel, Michael Miller. (2009) Cholesterol Goals: Moving from Numbers to Treatment. Clinical Cardiology 32:2, 106-108
CrossRef464
Serafina Valente, Chiara Lazzeri, Marco Chiostri, Cristina Giglioli, Andrea Sori, Sabrina Tigli, Gian Franco Gensini. (2009) NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. International Journal of Cardiology 132:1, 84-89
CrossRef465
Philippe Moulin. (2009) Interventions nutritionnelles en prévention cardiovasculaire secondaire : à propos de quelques idées reçues. Cahiers de Nutrition et de Diététique 44:1, 13-15
CrossRef466
Harald Tillmanns, Ali Erdogan, Daniel Sedding. (2009) Treatment of Chronic CAD – Do the Guidelines (ESC, AHA) Reflect Daily Practice?. Herz 34:1, 39-54
CrossRef467
Dean J. Kereiakes. (2009) Medical and catheter-based therapies for managing stable coronary disease: Lessons from the COURAGE trial. Current Treatment Options in Cardiovascular Medicine 11:1, 45-53
CrossRef468
Allen Jeremias, Sanjay Kaul, Todd K. Rosengart, Luis Gruberg, David L. Brown. (2009) The Impact of Revascularization on Mortality in Patients with Nonacute Coronary Artery Disease. The American Journal of Medicine 122:2, 152-161
CrossRef469
Ellis, Stephen G., . (2009) Refining the Art and Science of Coronary Stenting. New England Journal of Medicine 360:3, 292-294
Full Text470
Tonino, Pim A.L., De Bruyne, Bernard, Pijls, Nico H.J., Siebert, Uwe, Ikeno, Fumiaki, van `t Veer, Marcel, Klauss, Volker, Manoharan, Ganesh, Engstrøm, Thomas, Oldroyd, Keith G., Ver Lee, Peter N., MacCarthy, Philip A., Fearon, William F., . (2009) Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. New England Journal of Medicine 360:3, 213-224
Full Text471
Attilio Maseri, John F Beltrame, Hiroaki Shimokawa. (2009) Role of Coronary Vasoconstriction in Ischemic Heart Disease and Search for Novel Therapeutic Targets. Circulation Journal 73:3, 394-403
CrossRef472
Shinichiro Tanaka, Toshiyuki Noda, Tomonori Segawa, Taro Minagawa, Sachiro Watanabe, Shinya Minatoguchi. (2009) Relationship Between Functional Exercise Capacity and Functional Stenosis in Patients With Stable Angina and Intermediate Coronary Stenosis. Circulation Journal 73:12, 2308-2314
CrossRef473
Mitsuru Abe, Takeshi Kimura, Takeshi Morimoto, Yutaka Furukawa, Toru Kita. (2009) Incidence of and Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization in Japanese Patients. Circulation Journal 73:8, 1518-1522
CrossRef474
P. Stiefelhagen. (2009) Neue Studienergebnisse für den Internisten. Der Internist 50:1, 104-107
CrossRef475
Sinisa Stojkovic, Miodrag Ostojic, Milan Nedeljkovic, Goran Stankovic, Branko Beleslin, Vladan Vukcevic, Dejan Orlic, Aleksandra Arandjelovic, Jelena Kostic, Miodrag Dikic, Miloje Tomasevic. (2009) Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef476
Duminda N. Wijeysundera, Peter C. Austin, Janet E. Hux, W. Scott Beattie, Andreas Laupacis. (2009) Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. Journal of Clinical Epidemiology 62:1, 13-21.e5
CrossRef477
Jonathan W. Weinsaft, Shant J. Manoushagian, Taral Patel, Aqsa Shakoor, Robert J. Kim, Sunil Mirchandani, Fay Lin, Franklin J. Wong, Massimiliano Szulc, Peter M. Okin, Paul D. Kligfield, James K. Min. (2009) Stress-induced ST-segment deviation in relation to the presence and severity of coronary artery disease in patients with normal myocardial perfusion imaging. Coronary Artery Disease 20:1, 41-49
CrossRef478
H. F. McIntyre. (2009) Hypertension strategies in the third millennium: conservatism, evidence and the folly of speculation. International Journal of Clinical Practice 63:1, 7-14
CrossRef479
Dorinna D. Mendoza, Wm. Guy Weigold. (2009) Evaluation of myocardial viability by multidetector CT. Journal of Cardiovascular Computed Tomography 3:1, S2-S12
CrossRef480
Shiori Amemiya, Hidemasa Takao. (2009) Computed Tomographic Coronary Angiography for Diagnosing Stable Coronary Artery Disease. Circulation Journal 73:7, 1263-1270
CrossRef481
Teruo Inoue, Koichi Node. (2009) Molecular Basis of Restenosis and Novel Issues of Drug-Eluting Stents. Circulation Journal 73:4, 615-621
CrossRef482
Leonard Schwartz. (2009) Therapeutic options in coronary artery disease: Focusing on the guidelines. Canadian Journal of Cardiology 25:1, 19-24
CrossRef483
Dong-Bin Kim, Hae-Ok Jung, Doo-Soo Jeon, Chan-Seok Park, Sung-Won Jang, Hoon-Joon Park, Pum Joon Kim, Sang Hong Baek, Ki-Bae Seung, Tai-Ho Rho, Jae-Hyung Kim, Kyu-Bo Choi. (2009) Aortic Valve Sclerosis on Echocardiography is a Good Predictor of Coronary Artery Disease in Patients With an Inconclusive Treadmill Exercise Test. Korean Circulation Journal 39:7, 275
CrossRef484
Qi Zhang, Rui Yan Zhang, Jian Hu, Zhen Kun Yang, Jian Sheng Zhang, Feng Hua Ding, Run Du, Zheng Bin Zhu, Wei Feng Shen. (2009) Partial vs Full Coverage for Tandem Lesions in Culprit Vessel During Primary Coronary Intervention in Patients With Acute ST-Elevation Myocardial Infarction. Circulation Journal 73:12, 2236-2243
CrossRef485
David L. Wetzel, Louis H. Wetzel, Mark D. Wetzel, Robert. A. Lodder. (2009) Imminent cardiac risk assessment via optical intravascular biochemical analysis. The Analyst 134:6, 1099
CrossRef486
Gopal Ghimire, Jonathan Spiro, Rajesh Kharbanda, Micheal Roughton, Peter Barlis, Mark Mason, Charles Ilsley, Carlo Di Mario, Raimund Erbel, Ron Waksman, Miles Dalby. (2009) Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention 4:4, 481-484
CrossRef487
Steven P. Sedlis, William E. Boden, William S. Weintraub, David S. Maron, Robert A. O'Rourke, Daniel S. Berman, G. B. John Mancini, . (2009) Re: One year perspective on COURAGE. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef488
Todd W. Rice, Gordon R. Bernard. 2009. Acute Illnesses, Critical Care, Emergency and Surgical Patients. , 443-460.
CrossRef489
Azeem Latib, Alaide Chieffo, Antonio Colombo. (2008) Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina. Nature Clinical Practice Cardiovascular Medicine 6:2, 92-93
CrossRef490
M. Seyfarth, A. de Waha, J. Mehilli, J. Pache, A. Kastrati, A. Schömig. (2008) Prognostischer Wert einer perkutanen Koronarintervention bei Patienten mit stabiler Angina pectoris. Der Kardiologe 2:6, 479-487
CrossRef491
Jason H. Rogers. (2008) COURAGE: In the Eye of the Beholder. Preventive Cardiology 11:1, 5-7
CrossRef492
William B Runciman, G Ross Baker, Philippe Michel, Itziar Larizgoitia Jauregui, Richard J Lilford, Anne Andermann, Rhona Flin, William B Weeks. (2008) The epistemology of patient safety research. International Journal of Evidence-Based Healthcare 6:4, 476-486
CrossRef493
ROBERT L. WILENSKY. (2008) Vulnerable Plaque: Scope of the Problem. Journal of Interventional Cardiology 21:6, 443-451
CrossRef494
Bobbie Jean Sweitzer. (2008) Preoperative screening, evaluation, and optimization of the patientʼs medical status before outpatient surgery. Current Opinion in Anaesthesiology 21:6, 711-718
CrossRef495
Florian Schwarz, Balazs Ruzsics, U. Joseph Schoepf, Gorka Bastarrika, Salvatore A. Chiaramida, Joseph A. Abro, Robin L. Brothers, Sebastian Vogt, Bernhard Schmidt, Philip Costello, Peter L. Zwerner. (2008) Dual-energy CT of the heart—Principles and protocols. European Journal of Radiology 68:3, 423-433
CrossRef496
Miller, Julie M., Rochitte, Carlos E., Dewey, Marc, Arbab-Zadeh, Armin, Niinuma, Hiroyuki, Gottlieb, Ilan, Paul, Narinder, Clouse, Melvin E., Shapiro, Edward P., Hoe, John, Lardo, Albert C., Bush, David E., de Roos, Albert, Cox, Christopher, Brinker, Jeffery, Lima, João A.C., . (2008) Diagnostic Performance of Coronary Angiography by 64-Row CT. New England Journal of Medicine 359:22, 2324-2336
Full Text497
(2008) Quality of Life with PCI versus Medical Therapy in Stable Coronary Disease. New England Journal of Medicine 359:21, 2289-2293
Full Text498
J. Stirrup, K. Wechalekar, A. Maenhout, C. Anagnostopoulos. (2008) Cardiac radionuclide imaging in stable coronary artery disease and acute coronary syndromes. British Medical Bulletin 89:1, 63-78
CrossRef499
Serafina Valente, Chiara Lazzeri, Elisa Saletti, Marco Chiostri, Gian Franco Gensini. (2008) Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence. Journal of Cardiovascular Medicine 9:11, 1083-1087
CrossRef500
Claudio Moretti, Giuseppe GL Biondi-zoccai, Filippo Sciuto, Pierluigi Omedè, Maria Teresa Lucciola, Luisa Morena, Walter Grosso Marra, Gian Paolo Trevi, Imad Sheiban. (2008) Appraising the pathophysiologic impact of coronary collaterals as measured by fractional flow reserve on symptoms and signs of myocardial ischemia. Journal of Cardiovascular Medicine 9:11, 1120-1126
CrossRef501
Axel de Labriolle, Laurent Bonello, Probal Roy, Gilles Lemesle, Daniel H. Steinberg, Zhenyi Xue, Kimberly Kaneshige, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2008) Comparison of Safety, Efficacy, and Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in “True” Chronic Total Occlusions. The American Journal of Cardiology 102:9, 1175-1181
CrossRef502
Michael Lindstaedt. (2008) Patient stratification in left main coronary artery disease—Rationale from a contemporary perspective. International Journal of Cardiology 130:3, 326-334
CrossRef503
Ming-Chia Hsieh, Kai-Jen Tien, Shun-Jen Chang, Daw-Shyong Perng, Jeng-Yueh Hsiao, Yu-Wen Chen, Yu-Hung Chang, Hsuan-Wen Kuo, Pi-Chen Lin. (2008) High-sensitivity C-reactive protein and silent myocardial ischemia in Chinese with type 2 diabetes mellitus. Metabolism 57:11, 1533-1538
CrossRef504
L. H. Piers, R. Dikkers, T. P. Willems, B. J.G.L. de Smet, M. Oudkerk, F. Zijlstra, R. A. Tio. (2008) Computed tomographic angiography or conventional coronary angiography in therapeutic decision-making. European Heart Journal 29:23, 2902-2907
CrossRef505
Kim I. Cruz, Peter I. Tsai, William E. Cohn, Denton A. Cooley. (2008) Revascularization treatment recommendations based on atherosclerotic disease distribution: Coronary artery bypass grafting versus stenting. Current Atherosclerosis Reports 10:5, 434-437
CrossRef506
Mark D. Sullivan, Paul S. Ciechanowski, Joan E. Russo, John A. Spertus, Laurie A. Soine, Kier Jordan-Keith, James H. Caldwell. (2008) Angina pectoris during daily activities and exercise stress testing: The role of inducible myocardial ischemia and psychological distress. PAIN 139:3, 551-561
CrossRef507
David T Nash, Stephen D Nash. (2008) Ranolazine for chronic stable angina. The Lancet 372:9646, 1335-1341
CrossRef508
Thomas C. Gerber, Samuel J. Asirvatham, Carl J. Lavie, Jae K. Oh. (2008) Introduction to Symposium on Cardiovascular Diseases. Mayo Clinic Proceedings 83:10, 1168-1169
CrossRef509
Mauri, Laura, Silbaugh, Treacy S., Garg, Pallav, Wolf, Robert E., Zelevinsky, Katya, Lovett, Ann, Varma, Manu R., Zhou, Zheng, Normand, Sharon-Lise T., . (2008) Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. New England Journal of Medicine 359:13, 1330-1342
Full Text510
Steven E. Nissen. (2008) Tim russert and sudden cardiac death after myocardial infarction. Current Cardiology Reports 10:5, 343-344
CrossRef511
Grace A. Lin, R. Adams Dudley, Rita F. Redberg. (2008) Why Physicians Favor Use of Percutaneous Coronary Intervention to Medical Therapy: A Focus Group Study. Journal of General Internal Medicine 23:9, 1458-1463
CrossRef512
Robert A. O'Rourke. (2008) Optimal Medical Therapy Is a Proven Option for Chronic Stable Angina. Journal of the American College of Cardiology 52:11, 905-907
CrossRef513
Demosthenes G. Katritsis, Bernhard Meier. (2008) Percutaneous Coronary Intervention for Stable Coronary Artery Disease. Journal of the American College of Cardiology 52:11, 889-893
CrossRef514
J.R. González-Juanatey, E. González Babarro. (2008) ¿Qué ha cambiado en Cardiología en el último año? Implicaciones para la práctica clínica. Revista Clínica Española 208, 3-8
CrossRef515
Carl L. Tommaso. (2008) One year perspective on COURAGE. Catheterization and Cardiovascular Interventions 72:3, 426-429
CrossRef516
G. Robert Myers, William S. Weintraub. (2008) Medical therapies for chronic stable angina. Current Cardiovascular Risk Reports 2:5, 350-358
CrossRef517
Michael B. Fowler. (2008) Hypertension, Heart Failure, and Beta-Adrenergic Blocking Drugs
CrossRef518
Albert Schömig, Julinda Mehilli, Antoinette de Waha, Melchior Seyfarth, Jürgen Pache, Adnan Kastrati. (2008) A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease. Journal of the American College of Cardiology 52:11, 894-904
CrossRef519
S. Martin. (2008) Blutglukoseselbstkontrolle zum Selbstmanagement bei Typ-2-Diabetes. Der Diabetologe 4:6, 457-466
CrossRef520
Barry A Franklin, Justin E Trivax, Thomas E Vanhecke. (2008) New insights in preventive cardiology and cardiac rehabilitation. Current Opinion in Cardiology 23:5, 477-486
CrossRef521
Kamal Sharma, Mark J. Eisenberg. (2008) Putting the benefits of percutaneous coronary revascularization into perspective: From trials to guidelines. Current Cardiology Reports 10:5, 393-401
CrossRef522
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Roberto Ferrari. (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. The Lancet 372:9641, 807-816
CrossRef523
Peterson, Eric D., Rumsfeld, John S., . (2008) Finding the Courage to Reconsider Medical Therapy for Stable Angina. New England Journal of Medicine 359:7, 751-753
Full Text524
Weintraub, William S., Spertus, John A., Kolm, Paul, Maron, David J., Zhang, Zefeng, Jurkovitz, Claudine, Zhang, Wei, Hartigan, Pamela M., Lewis, Cheryl, Veledar, Emir, Bowen, Jim, Dunbar, Sandra B., Deaton, Christi, Kaufman, Stanley, O'Rourke, Robert A., Goeree, Ron, Barnett, Paul G., Teo, Koon K., Boden, William E., . (2008) Effect of PCI on Quality of Life in Patients with Stable Coronary Disease. New England Journal of Medicine 359:7, 677-687
Full Text525
P. P. Toth. (2008) Subclinical atherosclerosis: what it is, what it means and what we can do about it. International Journal of Clinical Practice 62:8, 1246-1254
CrossRef526
Marie-Claude Parent, Stéphane Rinfret. (2008) The unresolved issues with risk stratification and management of patients with coronary artery disease undergoing major vascular surgery. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 55:8, 542-556
CrossRef527
R. K. Patel, P. B. Mark, N. Johnston, R. McGeoch, M. Lindsay, D. B. Kingsmore, H. J. Dargie, A. G. Jardine. (2008) Prognostic Value of Cardiovascular Screening in Potential Renal Transplant Recipients: A Single-Center Prospective Observational Study. American Journal of Transplantation 8:8, 1673-1683
CrossRef528
Zuhier Awan, Khalid Al. Waili, Khalid Alrasadi, Jacques Genest. (2008) Treatment of low high-density lipoprotein cholesterol. Canadian Journal of Cardiology 24, 27C-31C
CrossRef529
Bertram Pitt. (2008) Medical therapy versus percutaneous coronary interventions for patients with stable and unstable coronary artery disease. Current Atherosclerosis Reports 10:4, 288-294
CrossRef530
David C. Levin, Vijay M. Rao. (2008) Turf Wars in Radiology: Updated Evidence on the Relationship Between Self-Referral and the Overutilization of Imaging. Journal of the American College of Radiology 5:7, 806-810
CrossRef531
Freidy Eid, William E. Boden. (2008) The evolving role of medical therapy for chronic stable angina. Current Cardiology Reports 10:4, 263-271
CrossRef532
Victor Cheng, Ariel Gutstein, Arik Wolak, Yasuyuki Suzuki, Damini Dey, Heidi Gransar, Louise E.J. Thomson, Sean W. Hayes, John D. Friedman, Daniel S. Berman. (2008) Moving Beyond Binary Grading of Coronary Arterial Stenoses on Coronary Computed Tomographic Angiography. JACC: Cardiovascular Imaging 1:4, 460-471
CrossRef533
Megan Coylewright, Roger S. Blumenthal, Wendy Post. (2008) Placing COURAGE in Context: Review of the Recent Literature on Managing Stable Coronary Artery Disease. Mayo Clinic Proceedings 83:7, 799-805
CrossRef534
C. Richard Conti. (2008) Expanding the Understanding of the Treatment of Chronic Angina: A 21st Century Approach–Part II. Clinical Cardiology 31:7, 295-296
CrossRef535
P A Ades, P D Savage, M J Toth, D J Schneider, M C Audelin, J Y Bunn, M Ludlow. (2008) The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease. International Journal of Obesity 32:6, 967-974
CrossRef536
Simon R. Dixon, Cindy L. Grines, William W. O'Neill. (2008) The Year in Interventional Cardiology. Journal of the American College of Cardiology 51:24, 2355-2369
CrossRef537
Subodh B. Joshi. (2008) Reversible ischemia as an indication for revascularization in stable angina–One more paradigm to challenge. American Heart Journal 155:6, e45
CrossRef538
Edward L. Hannan. (2008) Randomized Clinical Trials and Observational Studies. JACC: Cardiovascular Interventions 1:3, 211-217
CrossRef539
Anthony A Bavry, Deepak L Bhatt. (2008) Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. The Lancet 371:9630, 2134-2143
CrossRef540
Vincent Savarese, Intekhab Ahmed, Barry J. Goldstein. (2008) Coronary artery disease screening in patients with diabetes. Endocrine 33:3, 225-229
CrossRef541
Sharon L. Hale, John C. Shryock, Luiz Belardinelli, Michael Sweeney, Robert A. Kloner. (2008) Late sodium current inhibition as a new cardioprotective approach. Journal of Molecular and Cellular Cardiology 44:6, 954-967
CrossRef542
Boden, William E., Diamond, George A., . (2008) DTCA for PTCA — Crossing the Line in Consumer Health Education?. New England Journal of Medicine 358:21, 2197-2200
Full Text543
Georgios Sianos, Peter Barlis, Carlo Di Mario, Michail Papafaklis, Joachim Büttner, Alfredo Galassi, Joachim Schofer, Gerald Werner, Thierry Lefevre, Yves Louvard, Patrick Serruys, Nicolaus Reifart. (2008) European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the EuroCTO club. EuroIntervention 4:1, 84-92
CrossRef544
Gerald Werner, Carlo Di Mario, Alfredo Galassi, Anthony Gershlick, Bernhard Reimers, George Sianos, Horst Sievert, Thierry Lefevre, Nicolaus Reifart. (2008) Chronic total coronary occlusions and the Occluded Artery Trial. A critical appraisal.. EuroIntervention 4:1, 23-27
CrossRef545
William Wijns. (2008) Percutaneous Cardiovascular Intervention. The time has come for a big change.... EuroIntervention 4:1, 17-21
CrossRef546
Harmony R. Reynolds. (2008) Percutaneous and surgical revascularization procedures in women. Current Cardiovascular Risk Reports 2:3, 227-232
CrossRef547
Richard R. Heuser. (2008) Don't you care: You should. Catheterization and Cardiovascular Interventions 71:6, 726-726
CrossRef548
Tej Sheth, Shoaib Amlani, Mary Lou Ellins, Shamir Mehta, James Velianou, Gail Cappelli, Sean Yang, Madhu Natarajan. (2008) Computed tomographic coronary angiographic assessment of high-risk coronary anatomy in patients with suspected coronary artery disease and intermediate pretest probability. American Heart Journal 155:5, 918-923
CrossRef549
T. Thim, M. K. Hagensen, J. F. Bentzon, E. Falk. (2008) From vulnerable plaque to atherothrombosis. Journal of Internal Medicine 263:5, 506-516
CrossRef550
Mark W. Ketterer, W. Knysz, S.J. Keteyian, J. Schairer, S. Jafri, M. Alam, A.J. Farha, S. Deveshwar. (2008) Cardiovascular Symptoms in Coronary-Artery Disease Patients Are Strongly Correlated With Emotional Distress. Psychosomatics 49:3, 230-234
CrossRef551
Michael J. Lawson, Martin Tobi. (2008) Cecal Stampede: The Headlong Rush for Screening Colonoscopy: A Position Paper. Digestive Diseases and Sciences 53:4, 871-874
CrossRef552
Eddie Vos, Luca Mascitelli, Colin P. Rose. (2008) Regarding “Does simvastatin save lives; If so, when and in whom?”. Journal of Vascular Surgery 47:4, 900-901
CrossRef553
Joanne Frattaroli, Gerdi Weidner, Terri A. Merritt-Worden, Steven Frenda, Dean Ornish. (2008) Angina Pectoris and Atherosclerotic Risk Factors in the Multisite Cardiac Lifestyle Intervention Program. The American Journal of Cardiology 101:7, 911-918
CrossRef554
Andreas König, M Pauliina Margolis, Renu Virmani, David Holmes, Volker Klauss. (2008) Technology Insight: in vivo coronary plaque classification by intravascular ultrasonography radiofrequency analysis. Nature Clinical Practice Cardiovascular Medicine 5:4, 219-229
CrossRef555
William E. Boden, David J. Maron. (2008) Reducing Post-Myocardial Infarction Mortality in the Elderly. Journal of the American College of Cardiology 51:13, 1255-1257
CrossRef556
Binita Shah, Nidhi Kumar, Parveen Garg, Eunice Kang, Eugene Grossi, Jeffrey D. Lorin, Arthur Z. Schwartzbard, Howard Mass, Ann Danoff, Steven P. Sedlis. (2008) Metabolic syndrome does not impact survival in patients treated for coronary artery disease. Coronary Artery Disease 19:2, 71-77
CrossRef557
Helfried Metzler, Sibylle Kozek-Langenecker, Kurt Huber. (2008) Antiplatelet therapy and coronary stents in perioperative medicine – the two sides of the coin. Best Practice & Research Clinical Anaesthesiology 22:1, 81-94
CrossRef558
Mark Y. Chan, Richard C. Becker, Robert A. Harrington, Eric D. Peterson, Paul W. Armstrong, Harvey White, Keith A.A. Fox, E. Magnus Ohman, Matthew T. Roe. (2008) Noninvasive, medical management for non–ST-elevation acute coronary syndromes. American Heart Journal 155:3, 397-407
CrossRef559
Anthony N. DeMaria. (2008) Clinical Trials and Clinical Judgment. Journal of the American College of Cardiology 51:11, 1120-1122
CrossRef560
Manuel D. Cerqueira. (2008) The quest for the vulnerable cardiac patient using computed tomography angiography: A new beginning?. Journal of Cardiovascular Computed Tomography 2:2, 102-104
CrossRef561
James K. Min, Leo Hofstra, Swaminatha V. Gurudevan, Manuel D. Cerqueira. (2008) Imaging Highlights of the American Heart Association 2007 Scientifıc Sessions. JACC: Cardiovascular Imaging 1:2, 252-262
CrossRef562
David P. Taggart, Sanjay Kaul, William E. Boden, T. Bruce Ferguson, Robert A. Guyton, Michael J. Mack, Paul T. Sergeant, Richard J. Shemin, Peter K. Smith, Salim Yusuf. (2008) Revascularization for Unprotected Left Main Stem Coronary Artery Stenosis. Journal of the American College of Cardiology 51:9, 885-892
CrossRef563
Giora Landesberg, Morris Mosseri. (2008) PRO: Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery. Anesthesia & Analgesia 106:3, 759-763
CrossRef564
Steven E. Nissen. (2008) Courage under fire: What is the optimal approach to initial treatment of stable angina?. Current Cardiology Reports 10:2, 79-80
CrossRef565
Miklos D. Kertai. (2008) Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery: A Core Review. Anesthesia & Analgesia 106:3, 751-758
CrossRef566
Nico H.J. Pijls, Pepijn van Schaardenburg, Ganesh Manoharan, Erik Boersma, Jan-Willem Bech, Marcel van’t Veer, Frits Bär, Jan Hoorntje, Jacques Koolen, William Wijns, Bernard de Bruyne. (2008) Reply. Journal of the American College of Cardiology 51:11, 1123-1124
CrossRef567
G. Jackson. (2008) Chronic stable angina - revised guidelines from the American College of Cardiology and American Heart Association. International Journal of Clinical Practice 62:3, 353-353
CrossRef568
Umamahesh C. Rangasetty, Charles Y. Lui. (2008) Fractional Flow Reserve–Guided Intervention of Angiographically Nonsignificant Coronary Stenoses. Journal of the American College of Cardiology 51:11, 1123
CrossRef569
Javier Sanz, Pedro R. Moreno, Valentin Fuster. (2008) The Year in Atherothrombosis. Journal of the American College of Cardiology 51:9, 944-955
CrossRef570
Ajay J. Kirtane, Stephen G. Ellis, Keith D. Dawkins, Antonio Colombo, Eberhard Grube, Jeffrey J. Popma, Martin Fahy, Martin B. Leon, Jeffrey W. Moses, Roxana Mehran, Gregg W. Stone. (2008) Paclitaxel-Eluting Coronary Stents in Patients With Diabetes Mellitus. Journal of the American College of Cardiology 51:7, 708-715
CrossRef571
Monique A. Ford, Thomas G. Allison, Amir Lerman. (2008) New approaches to the concept of primary prevention of atherosclerosis. Current Treatment Options in Cardiovascular Medicine 10:1, 73-82
CrossRef572
Javier Bermejo, Javier Segovia, Fernando Alfonso. (2008) Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association 2007 (Orlando, EE.UU., 4-7 de noviembre de 2007). Revista Española de Cardiología 61:2, 185-193
CrossRef573
L. Lorgis, J.-C. Beer, M. Zeller, P. Buffet, I. L’Huillier, I. Miliani, C. Denis, N. Jacquiot, Y. Cottin. (2008) Prise en charge au long cours du coronarien stable. L’optimisation du traitement médical : un vrai objectif. Annales de Cardiologie et d'Angéiologie 57, 9-15
CrossRef574
Rajesh Peter. (2008) Therapy and clinical trials: diabetes and cardiovascular risk. Current Opinion in Lipidology 19:1, 101-103
CrossRef575
András Jánosi. (2008) A stabil angina pectoris optimális kezelési stratégiája az evidenciák alapján. Orvosi Hetilap 149:7, 293-298
CrossRef576
S. Weber. (2008) Évolution de la maladie coronaire : quelques minutes, quelques semaines, quelques décennies…. Annales de Cardiologie et d'Angéiologie 57, 2-8
CrossRef577
Helfried Metzler, Kurt Huber, Sibylle Kozek-Langenecker. (2008) Anaesthesia in patients with drug-eluting stents. Current Opinion in Anaesthesiology 21:1, 55-59
CrossRef578
Dávid Becker, Béla Merkely. (2008) A stabil angina pectoris invazív kezelési stratégiája az evidenciák alapján. Orvosi Hetilap 149:7, 299-304
CrossRef579
Maximilian Galonska, Franziska Ducke, Tereza Kertesz-Zborilova, Rudolf Meyer, Hans Guski, Friedrich D. Knollmann. (2008) Characterization of Atherosclerotic Plaques in Human Coronary Arteries With 16-Slice Multidetector Row Computed Tomography by Analysis of Attenuation Profiles. Academic Radiology 15:2, 222-230
CrossRef580
Claudia Walther, Sven Möbius-Winkler, Axel Linke, Mathias Bruegel, Joachim Thiery, Gerhard Schuler, Rainer Halbrecht. (2008) Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease. European Journal of Cardiovascular Prevention & Rehabilitation 15:1, 107-112
CrossRef581
Brian Buxton. (2008) THE ROLE OF STENTS IN THE CURRENT ERA: LONG-TERM ANTIPLATELET THERAPY AND LATE-STENT THROMBOSIS. ANZ Journal of Surgery 78:1-2, 2-5
CrossRef582
George A. Diamond, Sanjay Kaul. (2008) Prevention and Treatment. Journal of the American College of Cardiology 51:1, 46-48
CrossRef583
Ganesan Karthikeyan, Balram Bhargava. (2008) Taking interventional cardiology forward: hindsight, foresight and insight. EuroIntervention 3:4, 424-425
CrossRef584
G.L. Moneta. (2008) Optimal Medical Therapy with or without PCI for Stable Coronary Disease. Yearbook of Vascular Surgery 2008, 39-40
CrossRef585
Megan Coylewright, Roger S. Blumenthal, Wendy Post. (2008) COURAGE to be conservative. Current Cardiovascular Risk Reports 2:1, 1-2
CrossRef586
Hye Won Lee. (2008) Perioperative management for patients undergoing noncardiac surgery after percutaneous coronary intervention. Korean Journal of Anesthesiology 55:1, 1
CrossRef587
James E Stahl. (2008) Modelling Methods for Pharmacoeconomics and Health Technology Assessment. PharmacoEconomics 26:2, 131-148
CrossRef588
Spencer B. King, Sidney C. Smith, John W. Hirshfeld, Alice K. Jacobs, Douglass A. Morrison, David O. Williams. (2008) 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. Journal of the American College of Cardiology 51:2, 172-209
CrossRef589
(2008) 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 71:1, E1-E40
CrossRef590
Michael F. O’Rourke, Audrey Adji. (2008) Basis for use of central blood pressure measurement in office clinical practice. Journal of the American Society of Hypertension 2:1, 28-38
CrossRef591
Shinichiro Tanaka, Chiharu Yokoyama, Itta Kawamura, Nobuhiro Takasugi, Tomoki Kubota, Hiroaki Ushikoshi, Takuma Aoyama, Masanori Kawasaki, Kazuhiko Nishigaki, Genzou Takemura, Shinya Minatoguchi. (2008) Conservative Medication Follow-up for Over 20 Years of a Patient With Ischemic Heart Disease After Diagnosis of Chronic Total Occlusion of the 3 Main Coronary Arteries. Circulation Journal 72:7, 1205-1209
CrossRef592
Abhiram Prasad, Charanjit Rihal, David R. Holmes. (2008) The COURAGE trial in perspective. Catheterization and Cardiovascular Interventions
CrossRef593
B.J. Gersh. (2008) Optimal Medical Therapy with or without PCI for Stable Coronary Disease. Yearbook of Medicine 2008, 378-381
CrossRef594
Gillian M Keating. (2008) Ranolazine. Drugs 68:17, 2483-2503
CrossRef595
U. Sechtem. (2008) Therapie der stabilen Angina pectoris. Der Internist 49:1, 57-68
CrossRef596
J. Golledge, D.-A. Siew. (2008) Identifying the Carotid ‘High Risk’ Plaque: Is it Still a Riddle Wrapped up in an Enigma?. European Journal of Vascular and Endovascular Surgery 35:1, 2-8
CrossRef597
Inge Björkander, Lennart Forslund, Thomas Kahan, Mats Ericson, Claes Held, Nina Rehnqvist, Paul Hjemdahl. (2008) Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris. Cardiology 111:2, 126-133
CrossRef598
William E. Braun. 2008. Cardiovascular and Other Noninfectious Complications after Renal Transplantation in Adults. , 1009-1033.
CrossRef599
Anthony N. DeMaria, Jeroen J. Bax, Ori Ben-Yehuda, Paul Clopton, Gregory K. Feld, Geoffrey S. Ginsburg, Barry H. Greenberg, James D. Knoke, Wilbur Y.W. Lew, João A.C. Lima, Alan S. Maisel, Sanjiv M. Narayan, Jagat Narula, David J. Sahn, Sotirios Tsimikas. (2008) Highlights of the Year in JACC 2007. Journal of the American College of Cardiology 51:4, 490-512
CrossRef600
Chiara Melloni, L Kristin Newby. (2008) Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes (MERLIN TIMI-36) study. Expert Review of Cardiovascular Therapy 6:1, 9-16
CrossRef601
Cheng, Susan, Jarcho, John, . (2007) Management of Stable Coronary Disease — Polling Results. New England Journal of Medicine 357:24,
Full Text602
Yu-Zeng Xue, Le-Xin Wang, Hua-Zhi Liu, Xue-Wen Qi, Xiao-Hua Wang, Hai-Zhou Ren. (2007) l-carnitine as an Adjunct Therapy to Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction. Cardiovascular Drugs and Therapy 21:6, 445-448
CrossRef603
S. Möhlenkamp, R. Erbel. (2007) Integration von funktioneller und morphologischer nichtinvasiver Bildgebung in die Evaluation von Patienten mit intermediärer Vortestwahrscheinlichkeit für eine koronare Herzkrankheit. Clinical Research in Cardiology Supplements 2:5, V57-V67
CrossRef604
Elliott S. Fisher. (2007) 2007 Robert and Alma Moreton Lecture: Pay for Performance: More Than Rearranging the Deck Chairs?. Journal of the American College of Radiology 4:12, 879-885
CrossRef605
Toby C Trujillo, Paul P Dobesh. (2007) Traditional Management of Chronic Stable Angina. Pharmacotherapy 27:12, 1677-1692
CrossRef606
Todd M. Brown, Vera Bittner. (2007) Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Journal of Clinical Lipidology 1:6, 564-574
CrossRef607
Harald Gabriel, Senta Graf, Thomas Neunteufl. (2007) Chronische koronare Herzkrankheit. Wiener klinische Wochenschrift Education 2:3, 155-174
CrossRef608
Carsten Rist, Thorsten R. Johnson, Christoph R. Becker, Maximilian F. Reiser, Konstantin Nikolaou. (2007) New applications for noninvasive cardiac imaging: dual-source computed tomography. European Radiology Supplements 17:S6, 16-25
CrossRef609
Vincent E. Friedewald, Spencer B. King, Carl J. Pepine, George W. Vetrovec, William C. Roberts. (2007) The Editor’s Roundtable: Chronic Stable Angina Pectoris. The American Journal of Cardiology 100:11, 1635-1643
CrossRef610
R. S. Bardeleben, T. Münzel, U. Nixdorff. (2007) Diagnostik und Risikostratifikation der koronaren Herzkrankheit (KHK): Aktuelle Bedeutung der Stressechokardiographie. Clinical Research in Cardiology Supplements 2:5, V18-V27
CrossRef611
Ole Frøbert, Marcel van't Veer, Wilbert Aarnoudse, Ulf Simonsen, Jacques J. Koolen, Nico H.J. Pijls. (2007) Acute myocardial infarction and underlying stenosis severity. Catheterization and Cardiovascular Interventions 70:7, 958-965
CrossRef612
Julio C. Palmaz. (2007) Bring That Pioneering Spirit Back! A 25-Year Perspective on the Vascular Stent. CardioVascular and Interventional Radiology 30:6, 1095-1098
CrossRef613
Enas A. Enas, Vinod Chacko, Suraj George Pazhoor, Hancy Chennikkara, Heyer Paul Devarapalli. (2007) Dyslipidemia in South Asian patients. Current Atherosclerosis Reports 9:5, 367-374
CrossRef614
Harm H.H. Feringa, Stefanos E. Karagiannis, Radosav Vidakovic, Abdou Elhendy, Folkert J. ten Cate, Peter G. Noordzij, Ron T. van Domburg, Jeroen J. Bax, Don Poldermans. (2007) The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery. Coronary Artery Disease 18:7, 571-576
CrossRef615
U. Müller-Werdan, M. Meisel, P. Schirdewahn, K. Werdan. (2007) Ältere Patienten mit kardiovaskulären Erkrankungen. Der Internist 48:11, 1211-1219
CrossRef616
K. Lance Gould. (2007) Not All Randomized Trials Are Equal. Journal of the American College of Cardiology 50:20, 2013-2015
CrossRef617
Michele Coceani. (2007) Management of atrial fibrillation. The Lancet 370:9599, 1607
CrossRef618
James M. Brophy. (2007) Risk stratification following non-ST segment elevation myocardial infarction: Is the glass half-full or half-empty?. Canadian Journal of Cardiology 23:13, 1080-1081
CrossRef619
Roberto Ferrari, Michel E Bertrand, Willem J Remme, Maarten L Simoons, Jaap W Deckers, Kim M Fox. (2007) Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial. Expert Review of Cardiovascular Therapy 5:6, 1037-1046
CrossRef620
Michael J Mack. (2007) Clinical trials versus registries in coronary revascularization: which are more relevant?. Current Opinion in Cardiology 22:6, 524-528
CrossRef621
Lowell Satler. (2007) Angiography during PFO closure: “a glimpse of the future”. Catheterization and Cardiovascular Interventions 70:5, 646-646
CrossRef622
Sripal Bangalore, Franz H. Messerli. (2007) Is There an Ischemic Threshold Beyond Which Percutaneous Coronary Intervention Is Beneficial in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial?. The American Journal of Cardiology 100:9, 1495
CrossRef623
David P Taggart. (2007) Coronary artery bypass graft vs. percutaneous coronary angioplasty: CABG on the rebound?. Current Opinion in Cardiology 22:6, 517-523
CrossRef624
Dean J. Kereiakes, Paul S. Teirstein, Ian J. Sarembock, David R. Holmes, Mitchell W. Krucoff, William W. O’Neill, Ron Waksman, David O. Williams, Jeffrey J. Popma, Maurice Buchbinder, Roxana Mehran, Ian T. Meredith, Jeffrey W. Moses, Gregg W. Stone. (2007) The Truth and Consequences of the COURAGE Trial. Journal of the American College of Cardiology 50:16, 1598-1603
CrossRef625
George A. Diamond, Sanjay Kaul. (2007) COURAGE Under Fire. Journal of the American College of Cardiology 50:16, 1604-1609
CrossRef626
O. Schouten, D. Poldermans. (2007) Cardiac risk in non-cardiac surgery. British Journal of Surgery 94:10, 1185-1186
CrossRef627
John J. Mahmarian. (2007) Computed Tomography Coronary Angiography as an Anatomic Basis for Risk Stratification. Journal of the American College of Cardiology 50:12, 1171-1173
CrossRef628
H. J. M. G. Nelissen-Vrancken. (2007) Heeft preventieve toepassing van percutane coronaire interventie een toegevoegde waarde bij stabiele coronaire ziekten?. MFM 45:8, 236-237
CrossRef629
Thomas M Maddox, P Michael Ho, John S Rumsfeld. (2007) Health-related quality-of-life outcomes among coronary artery bypass graft surgery patients. Expert Review of Pharmacoeconomics & Outcomes Research 7:4, 365-372
CrossRef630
Spencer B King. (2007) The COURAGE trial: is there still a role for PCI in stable coronary artery disease?. Nature Clinical Practice Cardiovascular Medicine 4:8, 410-411
CrossRef631
Steffie Woolhandler, David U. Himmelstein. (2007) Double Catastrophe. Medical Care 45:8, 699-701
CrossRef632
Jeffrey L. Anderson, Cynthia D. Adams, Elliott M. Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin, A. Michael Lincoff, Eric D. Peterson, Pierre Theroux, Nanette Kass Wenger, R. Scott Wright, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Jonathan L. Halperin, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2007) ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 50:7, e1-e157
CrossRef633
(2007) PCI for Stable Coronary Disease. New England Journal of Medicine 357:4, 414-418
Full Text634
Benjamin M. Scirica, David A. Morrow. (2007) Ranolazine in patients with angina and coronary artery disease. Current Cardiology Reports 9:4, 272-278
CrossRef635
Dennis L. DeSilvey. (2007) The Courage to Treat and Not Touch. The American Journal of Geriatric Cardiology 16:4, 266-267
CrossRef636
Sanjay Kaul, Prediman K. Shah, George A. Diamond. (2007) As Time Goes By. Journal of the American College of Cardiology 50:2, 128-137
CrossRef637
Graham Jackson. (2007) Ranolazine - a nicely timed new medical therapy for stable angina. International Journal of Clinical Practice 61:7, 1063-1063
CrossRef638
Mark C Haigney. (2007) Ablation should not be first-line therapy for the treatment of atrial fibrillation. Expert Review of Cardiovascular Therapy 5:4, 673-679
CrossRef639
M. Ruß, E. Fleck, K. Graf, E. Gams, K. Werdan. (2007) Chronische koronare Herzkrankheit. Der Kardiologe 1:1, 55-70
CrossRef640
Bernhard Meier. (2007) Drug-Eluting Stents: The Next Chapter of the Coronary Stent Saga. The American Heart Hospital Journal 5:3, 173-176
CrossRef641
Barry A. Franklin. (2007) Lessons Learned From the COURAGE Trial: Generalizability, Limitations, and Implications. Preventive Cardiology 10:3, 117-120
CrossRef642
Richard A. Schatz. (2007) Stent Thrombosis in the Drug-Eluting Stent Age. The American Heart Hospital Journal 5:3, 138-140
CrossRef643
Sanjay Kaul, George A. Diamond. (2007) Current Status and Future Trends in Drug-Eluting Stents. The American Heart Hospital Journal 5:3, 165-168
CrossRef644
Philip R. Liebson. (2007) ILLUSTRATE and METEOR. Preventive Cardiology 10:3, 162-165
CrossRef645
Graham Jackson. (2007) Stable and also unstable coronary disease - COURAGE and the importance of optimal medical therapy. International Journal of Clinical Practice 61:6, 883-883
CrossRef646
Jagat Narula, H William Strauss. (2007) The popcorn plaques. Nature Medicine 13:5, 532-534
CrossRef647
Robert S Dieter, Aravinda Nanjundappa. (2007) Percutaneous coronary interventions: benefit, risk and cost–effectiveness. Future Cardiology 3:3, 233-234
CrossRef648
Hochman, Judith S., Steg, P. Gabriel, . (2007) Does Preventive PCI Work?. New England Journal of Medicine 356:15, 1572-1574
Full Text649
Shinro Matsuo, Kenichi Nakajima, Minoru Horie, Ichiro Nakae, Tsunehiko Nishimura, The J-ACCESS Investigators. (2007) Prognostic Value of Normal Stress Myocardial Perfusion Imaging in Japanese Population. Circulation Journal 72:4, 611-617
CrossRef
- Letters
